Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3047826	s-amh	ug/l (ug/l)	6290	7955	0.52%
3047826	s-amh	— (—)	787	1141	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Polycystic ovarian syndrome, broad definition

1122

2409

5.65

307.65

1.2

6.61

2.77

ug/l

27.08

1093

2284

Medical treatment for female infertility

2363

2799

10.61

307.65

1.3

1.2

3.10

3.26

ug/l

0.40

2277

2513

Female infertility, associated with anovulation

1024

468

29.20

307.65

1.2

6.23

3.24

ug/l

16.72

998

420

Endometriosis of pelvic peritoneum

470

485

9.75

307.65

1.3

1.5

2.18

4.97

ug/l

1.15

443

382

Procreative management

1134

1349

7.42

307.65

1.4

3.36

3.72

ug/l

0.57

1052

1132

Amenorrhoea

446

339

15.06

307.65

1.3

4.40

3.54

ug/l

1.29

398

303

Unspecified/other endometriosis

380

376

10.95

307.65

1.4

1.3

2.34

3.16

ug/l

1.49

354

317

Female infertility, cervical, vaginal, other or unspecified origin

3367

777

36.04

307.65

1.3

1.4

3.04

4.23

ug/l

0.73

3237

654

Endometriosis

922

764

7.38

307.65

1.3

1.4

2.44

4.20

ug/l

1.23

856

634

Female infertility

3516

809

33.23

307.65

1.2

1.4

3.61

4.21

ug/l

0.31

3387

682

Endometriosis of ovary

537

444

12.55

307.65

1.4

1.6

2.32

5.21

ug/l

1.00

507

335

Endometriosis diagnosis and infertility diagnosis occurring together

740

1029

8.34

307.65

1.3

2.51

3.53

ug/l

1.62

707

915

Female infertility, tubal origin

248

110

25.30

307.65

1.3

1.5

2.94

3.78

ug/l

0.27

234

Noninflammatory disorders of female genital tract

1653

930

9.47

307.65

1.3

1.4

4.05

4.09

ug/l

0.02

1576

789

Genitourinary diseases

725

621

5.94

294.95

1.3

1.5

4.38

5.95

ug/l

0.65

682

528

Ovarian cyst

684

833

4.87

244.10

1.5

1.4

3.48

4.18

ug/l

0.29

602

699

Malignant neoplasm of ovary, including Hilmo

205

128

17.34

244.04

4.4

1.1

22.72

2.94

ug/l

2.14

108

Complications associated with artificial fertilization

167

31.22

243.97

1.3

1.2

4.74

4.43

ug/l

0.06

162

Pain and other conditions associated with female genital organs and menstrual cycle

495

852

5.55

243.65

1.4

2.64

4.16

ug/l

1.19

478

729

Excessive, frequent and irregular menstruation

724

904

4.50

232.01

1.3

1.4

4.17

4.10

ug/l

0.03

664

766

Ovarian dysfunction

607

1550

4.54

219.13

1.3

7.79

3.29

ug/l

11.41

528

1484

Endometriosis of rectovaginal septum and vagina

195

151

13.65

205.36

1.5

2.15

3.64

ug/l

0.89

183

113

Medicines for HER+ breast cancer

488

1030

4.59

197.63

1.9

1.4

4.26

5.09

ug/l

0.39

368

771

Malignant neoplasm of ovary

153

18.46

187.70

5.1

1.2

24.75

3.02

ug/l

1.86

Polyp of the female genital tract

423

416

5.97

185.06

1.3

1.7

2.50

5.35

ug/l

0.84

359

300

Pregnancy examination and test

697

1250

3.69

177.09

1.3

4.37

3.32

ug/l

1.39

672

1107

Disorders of other endocrine glands

900

3201

2.84

175.90

1.4

1.3

6.65

3.37

ug/l

9.66

788

2928

L02BG Aromatase inhibitors

374

749

5.10

174.79

2.0

1.5

5.03

6.09

ug/l

0.34

283

536

Dysplasia of cervi uteri

453

736

4.58

165.95

1.3

1.4

3.55

4.24

ug/l

0.25

420

619

Polycystic ovarian syndrome

462

1287

4.17

148.26

1.2

1.3

8.88

3.16

ug/l

14.33

453

1242

Endometriosis of intestine

108

24.98

147.68

1.4

1.3

2.19

4.72

ug/l

0.53

100

Oligomenorrhoea

144

120

13.13

145.88

1.4

1.2

4.60

4.26

ug/l

0.12

136

104

Endometriosis ASRM stages 3,4

634

2196

3.01

136.17

1.4

1.3

2.35

3.57

ug/l

4.29

596

1950

Adenomyosis (Endometriosis of uterus)

177

226

8.04

129.77

1.4

1.9

2.17

3.77

ug/l

1.33

157

152

malignant neoplasm of female genital organs

191

266

7.33

128.85

4.4

1.1

20.49

2.72

ug/l

1.92

105

212

Supervision of high-risk pregnancy

610

1272

3.00

114.23

1.3

4.09

3.32

ug/l

1.38

571

1099

Persons encountering health services in circumstances related to reproduction

597

1495

2.72

100.22

1.4

4.74

4.63

ug/l

0.05

537

1229

Irregular menses

1221

5168

1.91

89.73

1.3

4.09

3.14

ug/l

2.19

1089

4708

Primary_lymphoid and hematopoietic malignant neoplasms

192

391

4.98

88.27

1.8

1.5

3.56

4.44

ug/l

0.39

154

326

Polycystic ovarian syndrome, consortium definition

1543

5273

1.76

83.59

1.3

4.97

3.16

ug/l

8.46

1395

4771

Liquid cancers, helper endpoint

244

546

3.93

80.08

1.6

1.2

3.28

3.38

ug/l

0.05

179

466

Personal history of malignant neoplasm

140

238

6.14

79.16

1.8

1.6

2.43

5.20

ug/l

1.44

118

195

Neoplasms

1493

4585

1.75

77.15

1.4

1.2

3.64

3.61

ug/l

0.03

1366

4387

Malignant neoplasm of breast, HER-positive

228

449

4.00

73.81

1.6

1.1

1.61

2.14

ug/l

1.94

120

325

Deep endometriosis

284

893

3.35

72.80

1.4

1.3

2.20

3.93

ug/l

3.01

269

807

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

128

215

6.05

72.76

1.7

1.2

3.02

2.90

ug/l

0.04

184

Malignant neoplasm of breast, ER-positive, including Hilmo

233

468

3.88

72.14

1.6

1.1

1.67

2.17

ug/l

1.79

124

343

Malignant neoplasm

794

2294

2.06

70.35

1.9

1.2

4.55

2.94

ug/l

1.13

558

2046

Primary ovarian failure

120

206

6.74

69.09

1.5

1.4

1.12

2.99

ug/l

2.46

187

Other noninflammatory disorders of vulva and perineum

135

255

5.43

67.98

1.4

1.5

3.05

3.47

ug/l

0.32

125

202

Spontaneous abortion

1080

4064

1.83

67.73

1.3

3.13

3.74

ug/l

1.70

1009

3640

Endometriosis ASRM stages 1,2

477

2062

2.39

65.61

1.3

2.20

3.51

ug/l

6.77

449

1850

Other abnormal products of conception

1035

3849

1.83

63.98

1.3

3.23

3.43

ug/l

0.27

982

3493

Secondary uncertain malignant neoplasm

108

178

6.16

62.62

1.8

1.2

3.23

2.96

ug/l

0.10

154

Malignant neoplasm, wide definition for exclusion

863

2687

1.90

60.42

1.9

1.2

4.32

2.93

ug/l

1.23

621

2426

Secondary and unspecified malignant neoplasm of lymph nodes

152

6.54

59.27

1.9

1.2

3.33

3.09

ug/l

0.08

135

Endocrine, nutritional and metabolic diseases

1332

4073

1.67

58.69

1.3

4.53

3.40

ug/l

2.85

1214

3753

Solid cancers, helper endpoint

736

2213

1.98

58.26

1.9

1.2

4.50

2.86

ug/l

1.04

514

1970

Other noninflammatory disorders of vagina

100

165

6.21

58.08

1.5

2.93

3.87

ug/l

0.51

126

Postpartum care and examination

438

1215

2.36

53.01

1.2

3.51

3.15

ug/l

0.78

417

1086

Disorders of the thyroid gland

1318

5386

1.61

52.69

1.3

3.10

3.73

ug/l

2.42

1198

4886

Outcome of delivery

446

1216

2.34

52.63

1.3

4.52

3.27

ug/l

2.04

425

1064

Malignant neoplasm of breast, HER2-negative

312

766

2.69

51.37

1.4

1.1

3.59

2.34

ug/l

0.27

181

609

Hodgkin lymphoma, hilmo

148

6.37

50.80

1.8

1.2

2.50

3.08

ug/l

0.77

134

Malignant neoplasm of breast

322

812

2.61

50.03

1.4

1.1

3.52

2.40

ug/l

0.25

190

652

Hypothyroidism, levothyroxine purchases

729

2215

1.90

49.73

1.3

1.2

3.43

3.49

ug/l

0.08

684

2123

Hypothyroidism and >3 levothyroxin purchases

729

2215

1.90

49.73

1.3

1.2

3.43

3.49

ug/l

0.08

684

2123

Hypothyroidism (congenital or acquired)

726

2217

1.89

48.63

1.3

1.2

3.43

3.49

ug/l

0.08

682

2125

Antenatal screening

500

1328

2.16

48.39

1.3

4.68

3.35

ug/l

2.72

468

1153

Menorrhagia

293

600

2.74

47.41

1.3

1.5

2.53

4.49

ug/l

0.93

263

473

Other abnormal uterine and vaginal bleeding

174

353

3.57

46.98

1.2

1.8

3.23

5.66

ug/l

0.55

152

257

L02BA Anti-estrogens

154

431

3.63

46.78

2.1

1.5

2.21

5.06

ug/l

1.17

102

305

Caries of enamel

1149

5206

1.60

46.75

1.3

3.36

3.71

ug/l

0.80

1059

4644

Malignant neoplasm of breast, HER2-negative, including Hilmo

330

876

2.46

45.49

1.4

1.1

3.46

2.41

ug/l

0.24

197

711

Malignant neoplasm of breast, including Hilmo

330

876

2.46

45.48

1.4

1.1

3.46

2.41

ug/l

0.24

197

711

Other menopausal disorders

166

247

3.82

45.22

1.3

2.0

1.04

7.71

ug/l

0.96

110

141

Other noninflammatory disorders of uterus, except cervix

115

162

4.82

44.52

1.8

2.2

8.97

11.00

ug/l

0.10

Benign neoplasm of ovary

184

605

3.09

43.25

2.1

1.5

4.00

4.89

ug/l

0.35

118

500

Special screening examination for infectious and parasitic diseases

657

2688

1.83

42.88

1.3

1.2

3.16

3.54

ug/l

1.56

622

2522

Hypopituitarism

107

247

4.45

42.65

1.6

1.4

4.74

3.95

ug/l

0.19

224

Hypothyroidism, other/unspecified

1236

5315

1.54

41.60

1.3

3.10

3.70

ug/l

2.16

1124

4818

Rare circulating lymphoid malignancy, including Hilmo

7.97

39.77

1.9

1.2

4.15

3.35

ug/l

0.21

Exclusions for E4_PCOS_BROAD

262

1083

2.47

39.61

1.4

3.57

4.54

ug/l

0.67

236

973

Hypothyreosis and Thyroxine purchase for inclusion criteria

1247

5440

1.51

38.82

1.3

3.08

3.68

ug/l

2.16

1135

4918

Finngen Rheumatological endpoints

569

5594

0.57

36.07

1.4

1.3

3.46

3.58

ug/l

0.12

494

5068

Other obstetric conditions, not elsewhere classified

1145

4860

1.53

36.07

1.2

1.3

3.38

3.41

ug/l

0.06

1088

4508

Other symptoms and signs involving the digestive system and abdomen

202

777

2.64

35.54

1.7

1.4

4.70

3.77

ug/l

0.31

133

671

Uterine polyps

136

5.29

35.25

1.6

2.2

2.24

4.28

ug/l

0.76

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1137

4841

1.53

35.05

1.2

1.3

3.36

3.41

ug/l

0.11

1083

4499

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

7.64

34.98

1.4

1.2

2.22

4.74

ug/l

0.71

Other complications of labour and delivery, not elsewhere classified

570

3077

1.78

33.11

1.2

3.60

3.39

ug/l

0.44

554

2911

GASTRO-related operations

1239

4229

1.48

32.76

1.4

1.2

3.87

3.57

ug/l

0.37

1132

3953

Any gastric operation

1239

4229

1.48

32.76

1.4

1.2

3.87

3.57

ug/l

0.37

1132

3953

Behavioural syndromes associated with physiological disturbances and physical factors

1138

5477

1.48

32.59

1.3

3.46

3.70

ug/l

0.46

1048

4911

Torsion of ovary, ovarian pedicle and fallopian tube

8.04

32.11

1.7

1.3

2.51

5.18

ug/l

0.65

Hypothyroidism, strict autoimmune

1068

4730

1.50

31.51

1.3

3.20

3.76

ug/l

1.60

975

4289

Gestational diabetes (for exclusion)

1093

5182

1.49

31.42

1.2

1.3

3.42

3.34

ug/l

0.23

1038

4749

Sleep disorders

1099

5427

1.47

30.55

1.2

1.3

3.28

3.67

ug/l

1.11

1010

4871

Ovarian dysfunction, other/unspecified

8.66

30.42

1.6

1.1

2.07

2.65

ug/l

0.39

Insomnia

1118

5633

1.46

29.31

1.2

1.3

3.16

3.68

ug/l

2.12

1030

5070

Diabetes, insulin treatment (Kela reimbursement)

271

3298

0.49

29.08

1.4

3.55

3.92

ug/l

0.41

214

2812

Lymphoid leukaemia

101

5.56

28.71

2.0

1.4

4.22

3.37

ug/l

0.21

All anxiety disorders

982

5321

1.47

27.43

1.3

3.40

3.57

ug/l

0.37

901

4848

Salpingitis and oophoritis

186

780

2.42

27.39

1.6

1.4

3.30

4.06

ug/l

0.23

160

619

Exclusions for E4_PCOS_CONSORTIUM

1135

4981

1.44

27.19

1.6

1.2

4.50

3.31

ug/l

1.23

938

4610

Statin medication

254

2871

0.49

27.04

1.3

2.87

3.59

ug/l

1.07

196

2504

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

270

3179

0.51

26.43

1.4

3.55

3.81

ug/l

0.26

214

2713

Diseases of oesophagus, stomach and duodenum

515

4997

0.61

25.57

1.3

4.27

3.53

ug/l

0.41

443

4452

Anxiety (asthma-related co-morbidities)

940

5017

1.46

25.39

1.3

3.43

3.74

ug/l

0.67

860

4553

Other heart diseases, wide

484

4848

0.61

25.13

1.3

4.10

3.70

ug/l

0.11

398

4328

Serous carcinoma of ovary, including Hilmo

9.87

25.07

3.3

1.1

10.53

3.17

ug/l

—

Dentofacial anomalies [including malocclusion]

1004

5663

1.43

24.78

1.3

3.03

3.71

ug/l

2.70

921

5109

Nerve, nerve root and plexus disorders

504

4982

0.62

24.55

1.3

3.21

3.49

ug/l

0.30

422

4443

Postpartum haemorrhage

648

3552

1.56

24.02

1.2

1.3

3.92

3.33

ug/l

0.46

605

3231

Neurotic, stress-related and somatoform disorders

1082

5417

1.40

23.44

1.3

3.50

3.75

ug/l

0.40

974

4872

Pain in throat and chest

466

4529

0.61

23.00

1.3

2.96

3.82

ug/l

2.35

406

4081

Anxiety disorders

1082

5417

1.40

22.90

1.3

3.50

3.74

ug/l

0.38

974

4872

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1147

4492

1.39

22.74

1.4

1.3

3.64

3.81

ug/l

0.17

1008

4053

Any event in cancer register

1014

4231

1.42

22.55

1.8

1.2

4.46

3.10

ug/l

1.16

776

3922

Routine general health check-up of defined subpopulation

166

4.06

22.28

2.1

1.3

2.80

4.70

ug/l

1.42

155

Non-Hodgkin lymphoma, all, including Hilmo

114

4.59

22.13

1.9

1.1

3.97

2.93

ug/l

0.17

Ectopic pregnancy

289

1569

1.87

21.75

1.3

2.94

4.31

ug/l

1.85

267

1377

Polyarthropathies

291

3411

0.55

21.72

1.4

1.3

4.21

3.66

ug/l

0.35

257

3044

Influenza and pneumonia

642

6077

0.67

21.57

1.3

3.20

3.75

ug/l

1.70

556

5492

Diarrhoea and gastroenteritis of presumed infectious origin

1102

5286

1.38

21.41

1.3

3.20

3.83

ug/l

2.06

1000

4745

Congenital malformations of genital organs

246

1295

1.94

20.29

1.4

1.3

4.50

4.01

ug/l

0.20

222

1212

Other intervertebral disc disorders

373

3698

0.60

19.90

1.3

4.04

3.53

ug/l

0.20

301

3308

Fall on same level

792

6116

0.70

19.79

1.4

1.3

3.73

3.71

ug/l

0.02

696

5549

All pneumoniae

560

5593

0.67

19.35

1.3

3.29

3.75

ug/l

0.83

482

5015

Pneumonias (Asthma/COPD co-morbidities)

552

5543

0.67

19.17

1.3

3.28

3.75

ug/l

0.85

474

4972

Hypothyroidism, strict autoimmune, 3 medication purchases required

1071

5344

1.36

19.12

1.3

3.19

3.64

ug/l

1.24

966

4823

Artrosis, including avohilmo

267

2600

0.56

19.07

1.4

2.65

3.59

ug/l

0.81

210

2206

Malignant neoplasm of breast, HER-negative

304

2.89

19.04

1.4

1.1

7.33

2.47

ug/l

0.40

232

Sleep apnoea, including avohilmo

326

3394

0.59

18.97

1.4

3.64

3.58

ug/l

0.03

245

2915

Abnormalities of breathing

650

5440

0.69

18.26

1.3

3.25

3.79

ug/l

1.12

563

4964

Chromosomal abnormalities, not elsewhere classified

212

3.39

18.08

1.4

4.73

3.90

ug/l

0.17

194

Other maternal disorders predominantly related to pregnancy

995

4598

1.37

18.03

1.3

3.98

3.56

ug/l

0.54

923

4106

Diabetes mellitus in pregnancy

930

4357

1.39

17.99

1.3

3.69

3.28

ug/l

1.40

889

3988

Postmenopausal bleeding

121

3.41

17.98

2.1

3.0

2.61

26.20

ug/l

0.75

Autoimmune diseases excluding thyroid diseases, strict definition

624

4952

0.69

17.96

1.2

1.3

3.27

3.94

ug/l

2.10

557

4488

Periodontitis

338

3697

0.61

17.75

1.6

1.3

2.71

3.68

ug/l

2.71

269

3208

Chronic apical periodontitis

751

5983

0.71

17.73

1.4

1.3

3.30

3.63

ug/l

0.57

645

5437

Cardiac arrhythmias

354

3712

0.62

17.60

1.4

1.3

4.60

3.53

ug/l

0.25

302

3321

Malignant neoplasm of breast, ER-negative, including Hilmo

104

389

2.56

17.56

1.4

1.1

6.42

2.49

ug/l

0.38

305

Chronic periodontitis, including avohilmo

336

3673

0.61

17.45

1.6

1.3

2.70

3.69

ug/l

2.80

268

3185

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

519

5255

0.67

17.43

1.3

3.26

3.78

ug/l

0.92

443

4701

Complications of labour and delivery

968

3957

1.37

17.43

1.3

3.98

3.58

ug/l

0.38

888

3517

Autoimmune diseases excluding thyroid diseases

648

5059

0.70

17.38

1.2

1.3

3.23

3.90

ug/l

2.20

579

4582

Family history of malignant neoplasm

173

855

2.06

17.31

1.5

1.3

2.63

4.12

ug/l

1.93

137

756

Supervision of normal pregnancy

377

1314

1.66

17.08

1.3

4.60

3.32

ug/l

1.85

349

1140

Benign leiomyoma with endometriosis

105

423

2.51

17.04

1.3

1.6

1.94

4.06

ug/l

1.64

298

Symptoms and signs involving cognition, perception, emotional state and behaviour

485

4928

0.67

16.65

1.4

1.3

3.15

3.71

ug/l

1.33

413

4387

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

550

4855

0.68

16.64

1.3

3.02

3.75

ug/l

2.37

472

4382

550

4855

0.68

16.64

1.3

3.02

3.75

ug/l

2.37

472

4382

Perineal laceration during delivery

589

3410

1.48

16.62

1.2

3.58

3.32

ug/l

0.62

561

3189

All kidney diseases

620

5991

0.70

15.98

1.4

1.3

4.43

3.61

ug/l

0.90

520

5428

Disorders of gallbladder, biliary tract and pancreas

401

3877

0.65

15.75

1.3

1.4

2.74

3.59

ug/l

2.18

318

3390

Cardiovascular diseases (excluding rheumatic etc)

692

5516

0.72

15.66

1.3

3.05

3.52

ug/l

1.05

602

5123

Tonsillectomy and adenotomy

1019

5378

1.33

15.60

1.3

3.56

3.54

ug/l

0.04

950

4936

Congenital malformations of uterus and cervix

355

2.68

15.42

1.3

3.60

3.32

ug/l

0.30

333

Donors of organs and tissues

4.43

15.29

1.3

3.11

3.28

ug/l

0.15

Maternal care for known or suspected fetal abnormality and damage

499

2931

1.50

15.18

1.2

1.3

3.23

3.14

ug/l

0.19

479

2713

Long labour

563

3367

1.45

14.99

1.3

3.40

3.30

ug/l

0.16

532

3057

Oral corticosteroids

662

5444

0.72

14.94

1.4

1.3

2.79

3.67

ug/l

2.74

580

4888

Migraine, single triptan purchase ok & required. ICD-code if available is included

1022

5291

1.31

14.65

1.3

3.68

3.65

ug/l

0.03

933

4768

Triptan medication for migraine, single purchase ok

1022

5291

1.31

14.65

1.3

3.68

3.65

ug/l

0.03

933

4768

Labour and delivery complicated by fetal stress [distress]

732

3502

1.39

14.57

1.3

1.2

3.35

3.34

ug/l

0.02

691

3235

Substance abuse, excluding more controls

222

3247

0.58

14.54

1.2

1.3

4.71

3.62

ug/l

0.33

195

2949

Pain in limb

566

5339

0.71

14.41

1.3

3.08

3.78

ug/l

1.55

493

4868

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

180

3.14

14.24

1.5

1.1

1.89

2.52

ug/l

0.63

131

Disorders of tooth development and eruption

300

1493

1.65

14.24

1.4

1.2

3.68

3.64

ug/l

0.04

282

1384

Congenital malformations, deformations and chromosomal abnormalities

858

5972

1.33

14.02

1.4

1.3

3.77

3.63

ug/l

0.15

772

5447

Pneumonia, organism unspecified

447

4579

0.68

13.98

1.4

1.3

3.26

3.86

ug/l

0.94

382

4071

Anxiety disorders, excluding more controls

917

4521

1.32

13.89

1.3

3.43

3.73

ug/l

0.46

818

4058

Intracranial trauma

416

4319

0.67

13.81

1.3

4.05

3.84

ug/l

0.10

377

3954

Premature rupture of membranes

621

3207

1.41

13.54

1.2

1.3

3.80

3.22

ug/l

0.51

580

2960

Benign neoplasms

1221

5296

1.28

13.53

1.4

1.3

3.34

3.64

ug/l

0.53

1098

4924

Sleep apnoea

252

2673

0.61

13.45

1.4

3.89

3.74

ug/l

0.06

182

2226

Arthrosis

171

1705

0.55

13.36

1.6

1.4

3.34

3.72

ug/l

0.14

129

1393

Single delivery by caesarean section

526

2115

1.45

13.09

1.2

1.3

3.76

2.99

ug/l

1.79

499

1926

Non-follicular lymphoma

4.03

13.07

1.9

1.5

1.43

6.18

ug/l

0.91

Asthma/COPD (KELA code 203)

640

5965

0.73

13.03

1.4

1.3

3.62

3.75

ug/l

0.14

571

5389

Non-invasive ventilation

1422

0.40

12.82

1.4

1.3

3.96

3.72

ug/l

0.05

1272

Postpartum hemorraghe, parous women as controls

648

4066

1.38

12.72

1.2

1.3

3.92

3.54

ug/l

0.26

605

3762

Spondylopathies

198

2027

0.58

12.60

1.4

3.42

3.92

ug/l

0.23

144

1698

Congenital ovarian cysts

126

631

2.07

12.56

1.5

1.3

4.63

3.56

ug/l

0.25

110

589

Cholelithiasis, broad definition with cholecystitis

347

3503

0.66

12.45

1.3

1.4

2.78

3.58

ug/l

1.70

280

3031

Agranulocytosis

361

2.38

12.45

1.8

1.5

2.58

4.26

ug/l

1.11

305

Contraceptive management

308

1372

1.58

12.38

1.3

1.4

4.38

3.93

ug/l

0.14

261

1136

Postprocedural endocrine and metabolic disorders, not elsewhere classified

150

799

1.90

12.20

1.9

1.4

1.98

4.10

ug/l

3.30

113

700

Use of hypnotics and sedatives

564

4452

0.72

12.16

1.4

1.3

2.68

3.56

ug/l

2.93

472

3949

Recurrent or chronic depression

500

2480

1.43

12.15

1.2

1.3

2.97

3.91

ug/l

2.10

451

2221

Hypertensive diseases (excluding secondary)

233

2201

0.61

12.03

1.7

1.3

3.51

3.45

ug/l

0.03

180

1914

Pregnancy, childbirth and the puerperium

439

1567

1.48

12.01

1.3

1.4

4.01

3.24

ug/l

2.71

416

1401

Hypertensive diseases

256

2295

0.63

11.86

1.7

1.3

3.56

3.69

ug/l

0.06

183

1907

Transplanted organ and tissue status

232

2.70

11.83

1.9

1.5

3.36

5.27

ug/l

0.47

205

Pregnancy with abortive outcome

1072

4409

1.28

11.79

1.3

3.67

3.80

ug/l

0.13

998

3958

Hypertension

256

2289

0.63

11.74

1.7

1.3

3.56

3.69

ug/l

0.06

183

1901

Cholelithiasis

333

3424

0.67

11.68

1.3

1.4

2.86

3.57

ug/l

1.34

266

2954

Inflammatory bowel disease treatment related agents

827

5988

0.77

11.65

1.4

1.3

2.92

3.80

ug/l

3.43

736

5417

Shoulder lesions

209

2082

0.61

11.36

1.4

2.35

3.97

ug/l

2.88

150

1735

202

2920

0.61

11.25

1.3

3.31

3.81

ug/l

0.87

181

2645

Other metabolic disorders

154

854

1.82

11.07

1.9

1.4

2.05

3.98

ug/l

3.07

117

746

Mental and behavioural disorders due to psychoactive substance use

231

3386

0.63

11.02

1.2

1.3

4.69

3.63

ug/l

0.33

203

3083

Lower back pain or/and sciatica

713

6076

0.76

10.92

1.3

3.43

3.58

ug/l

0.11

611

5510

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

355

3306

0.69

10.85

1.6

1.3

3.39

3.55

ug/l

0.10

270

2844

Cystitis

1072

5088

1.26

10.82

1.3

3.45

3.66

ug/l

0.32

974

4592

ILD medications: prednisolone, methylprednisolone, prednisone

800

5756

0.77

10.76

1.4

1.3

2.86

3.79

ug/l

3.12

706

5219

Disorders of puberty, all

231

2.70

10.65

1.6

1.4

7.66

3.95

ug/l

1.25

219

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

867

5397

1.28

10.48

1.2

1.3

3.25

3.52

ug/l

0.29

795

4873

Headache

800

4971

1.29

10.47

1.4

1.3

4.07

3.72

ug/l

0.30

714

4518

Disorders of puberty

170

2.97

10.46

1.6

1.4

8.60

3.39

ug/l

1.47

164

Low back pain

549

5284

0.74

10.38

1.3

3.44

3.64

ug/l

0.12

477

4836

Persons encountering health services in other circumstances, wide

1088

4492

1.25

10.26

1.4

1.3

3.57

3.81

ug/l

0.26

956

4053

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

294

1962

1.51

10.14

1.4

3.34

4.02

ug/l

0.51

259

1704

Obstructed labour due to malposition and malpresentation of fetus

472

3209

1.39

10.13

1.3

3.49

3.23

ug/l

0.50

440

2897

Hernia

361

3458

0.70

10.10

1.6

1.3

3.25

3.78

ug/l

0.72

290

2988

186

2733

0.61

10.04

1.2

1.3

3.28

3.85

ug/l

1.02

167

2481

Persons encountering health services for specific procedures and health care

752

5776

0.78

9.92

1.5

1.3

3.42

3.73

ug/l

0.26

640

5234

Renal tubulo-interstitial diseases

512

5124

0.74

9.89

1.4

1.3

3.65

3.74

ug/l

0.09

429

4610

Congenital malformations of ovaries, fallopian tubes and broad ligaments

134

743

1.85

9.88

1.5

1.3

4.52

3.96

ug/l

0.12

117

689

Atopic dermatitis

858

5570

1.27

9.81

1.3

3.61

3.58

ug/l

0.03

792

5078

Injuries to the shoulder and upper arm

309

3628

0.68

9.81

1.2

1.4

3.24

4.14

ug/l

2.03

265

3186

Maternal care related to the fetus and amniotic cavity and possible delivery problems

788

3609

1.29

9.75

1.2

1.3

4.38

3.50

ug/l

1.05

725

3243

Substance abuse

222

3225

0.64

9.62

1.2

1.3

4.71

3.62

ug/l

0.33

195

2936

Malignant neoplasm of corpus uteri, including Hilmo

4.19

9.62

1.7

1.1

0.49

2.41

ug/l

2.40

Other arrhythmias

270

3035

0.67

9.61

1.4

1.3

2.80

3.70

ug/l

2.29

226

2636

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

4.60

9.52

1.6

1.1

2.43

2.99

ug/l

0.25

Dyspnoea

446

4485

0.73

9.39

1.4

1.3

3.17

3.73

ug/l

0.78

370

3981

Other specific joint derangements/joint disorders

661

5505

0.77

9.31

1.3

3.61

3.65

ug/l

0.03

580

5063

Inflammatory diseases of female pelvic organs

972

5773

1.24

9.28

1.4

1.3

3.13

3.63

ug/l

0.89

871

5222

Other disorders of ear

331

3082

0.70

9.04

1.5

1.4

3.17

4.04

ug/l

0.97

277

2635

Congenital malformations, deformations and chromosomal abnormalities

782

5909

1.27

9.03

1.4

1.3

3.82

3.53

ug/l

0.31

701

5416

Tramadol

384

3274

0.72

9.01

1.6

1.3

2.81

3.48

ug/l

0.86

321

2886

Other disorders of urethra and urinary system

460

4468

0.74

9.01

1.3

3.27

3.70

ug/l

0.62

406

3997

Factors influencing health status and contact with health services

144

402

1.80

8.92

1.4

1.3

3.22

5.29

ug/l

1.03

128

327

Postmenopausal atrophic vaginitis

141

2.47

8.89

1.2

2.7

2.14

18.90

ug/l

0.79

Enlarged lymph nodes

143

830

1.74

8.87

1.6

1.3

3.45

4.00

ug/l

0.43

121

742

Other anxiety disorders

759

5211

1.27

8.84

1.3

3.56

3.54

ug/l

0.02

706

4809

Suicide or other Intentional self-harm

123

2131

0.57

8.74

1.2

1.3

3.06

3.71

ug/l

1.11

109

1947

Other septicaemia

169

989

1.65

8.68

1.6

1.4

4.03

4.79

ug/l

0.31

133

855

Condition for Implicit Sepsis (Organ dysfunction codes)

468

4310

0.75

8.68

1.4

1.3

3.42

3.85

ug/l

0.77

407

3833

Hypertension, essential

237

2014

0.66

8.58

1.9

1.3

3.64

3.61

ug/l

0.01

159

1644

Leiomyoma of uterus

493

2083

1.35

8.40

1.5

1.4

4.62

3.27

ug/l

0.53

371

1702

Follow-up examination after treatment for malignant neoplasms

138

2.84

8.36

2.7

1.7

1.98

8.32

ug/l

0.90

Intestinal infectious diseases

1104

5196

1.22

8.34

1.3

3.14

3.84

ug/l

2.94

993

4662

Other diseases of blood and blood-forming organs, wide

130

753

1.74

8.14

1.6

1.4

2.53

4.09

ug/l

2.26

642

Drug-induced neutropenia

176

2.58

8.00

2.1

1.5

1.41

4.45

ug/l

1.23

144

Malignant neoplasm of other connective and soft tissue, including Hilmo

4.16

8.00

2.6

1.2

1.69

3.54

ug/l

1.22

Injuries to the knee and lower leg

887

6033

0.81

7.91

1.4

1.3

3.93

3.68

ug/l

0.36

774

5471

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

319

3926

0.71

7.88

1.3

4.29

3.90

ug/l

0.40

304

3759

Short stature, not elsewhere classified

239

2.33

7.87

1.7

1.4

11.50

4.51

ug/l

1.13

229

Delivery, wide proxy

505

2028

1.33

7.85

1.3

4.45

3.09

ug/l

4.72

476

1827

Female genital prolapse

276

1.95

7.75

1.4

1.9

5.33

7.41

ug/l

0.21

171

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

236

2185

0.68

7.74

1.5

1.3

3.68

3.41

ug/l

0.13

179

1914

Malignant neoplasm of urinary organs

5.91

7.67

1.6

1.1

1.41

2.99

ug/l

1.14

Other diseases of intestines

858

5977

0.81

7.66

1.3

3.03

3.81

ug/l

3.60

760

5448

Type 2 diabetes, wide definition

135

1421

0.61

7.57

1.5

2.43

4.50

ug/l

2.08

1100

Melanocytic naevi

327

2371

1.39

7.39

1.3

3.60

3.63

ug/l

0.02

284

2149

Molar incisor enamel hypoplasia

454

1.92

7.35

1.6

1.3

6.30

5.12

ug/l

0.27

431

Mycoses

846

6024

1.22

7.33

1.3

3.46

3.66

ug/l

0.21

775

5424

Chronic diseases of tonsils and adenoids

911

4731

1.22

7.30

1.3

3.53

3.84

ug/l

0.58

832

4268

Failed induction of labour

209

1412

1.52

7.26

1.2

1.3

2.99

3.49

ug/l

0.92

195

1335

Other bacterial diseases

536

4350

0.78

7.19

1.5

1.3

3.59

3.87

ug/l

0.25

421

3871

Ischemic heart diseases

1029

0.57

7.17

1.7

1.6

1.83

5.46

ug/l

2.90

709

Hyperkinetic disorders

156

2364

0.64

7.17

1.2

1.3

4.41

4.05

ug/l

0.18

151

2252

Mental and behavioural disorders due to alcohol

171

2511

0.65

7.17

1.2

1.3

3.28

3.58

ug/l

0.48

152

2273

Unspecified mental disorder

228

3288

0.69

7.15

1.4

1.3

3.35

3.61

ug/l

0.35

197

2999

Medical abortion

643

4367

0.79

7.12

1.3

3.45

3.80

ug/l

0.27

582

3917

Appendectomy

696

5363

1.24

7.12

1.6

1.3

5.24

3.28

ug/l

0.94

588

4852

Injuries to the head

815

6110

0.82

7.08

1.4

1.3

3.72

3.71

ug/l

0.01

728

5519

Malignant neoplasm of kidney, except renal pelvis

5.61

7.05

1.7

1.1

1.41

2.99

ug/l

1.14

Condition for Implicit Sepsis (Organ dysfunction codes)

376

3540

0.75

7.03

1.5

1.3

3.49

3.97

ug/l

0.69

321

3131

Alcohol use disorder, Swedish definition

160

2262

0.65

7.00

1.3

3.23

3.84

ug/l

0.89

144

2021

Kela-code for severe mental illness

172

2607

0.66

6.99

1.3

3.49

3.73

ug/l

0.24

144

2369

Conjunctivitis

873

6018

1.22

6.98

1.3

3.46

3.76

ug/l

0.56

787

5432

Disturbance of activity and attention

151

2290

0.64

6.96

1.2

1.3

4.40

3.98

ug/l

0.21

146

2186

Hard cardiovascular diseases

127

1237

0.61

6.92

1.9

1.5

3.63

4.98

ug/l

0.50

895

Abnormal findings in secretions and smears from cervix uteri vagina vulva

860

5362

1.22

6.91

1.2

1.3

3.24

3.52

ug/l

0.29

788

4846

Chronic lower respiratory diseases

934

5979

0.83

6.86

1.3

3.37

3.76

ug/l

0.82

845

5402

Depression

985

5568

1.20

6.84

1.3

3.06

3.75

ug/l

3.16

889

5017

Acute upper respiratory infections of multiple and unspecified sites

847

5172

1.22

6.81

1.3

3.29

3.75

ug/l

1.26

781

4683

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

104

1750

0.59

6.77

1.2

1.3

2.68

3.82

ug/l

3.01

1622

Balanced rearrangements and structural markers, not elsewhere classified

4.57

6.76

1.4

1.3

2.51

3.10

ug/l

0.37

Complications of the puerperium, not elsewhere classified

115

687

1.72

6.75

1.2

1.3

3.16

4.05

ug/l

0.77

110

639

Hypoplasia of dental enamel , including avohilmo

431

1.90

6.67

1.7

1.3

6.56

5.08

ug/l

0.34

408

Used for control exclusion in common control thyroid runs

1136

4841

1.19

6.66

1.3

3.46

3.92

ug/l

1.17

1042

4397

Benzodiazepine use

697

5892

0.81

6.61

1.3

3.00

3.61

ug/l

2.15

596

5329

Haemorrhage in early pregnancy

483

3674

1.29

6.59

1.2

1.3

3.18

3.23

ug/l

0.09

450

3299

Hyperkinetic disorders, excluding more controls

156

2264

0.65

6.54

1.2

4.41

3.80

ug/l

0.34

151

2177

Lumbar disc prolapse

287

3011

0.73

6.46

1.3

1.4

4.59

3.57

ug/l

0.34

231

2643

Other endocrine disorders

401

1.89

6.43

1.7

1.3

9.00

4.02

ug/l

1.04

381

ILD medications

910

5905

0.83

6.42

1.4

1.3

2.98

3.82

ug/l

2.99

808

5363

Septicaemia

181

1128

1.50

6.40

1.7

1.4

4.00

4.83

ug/l

0.38

142

975

Malignant neoplasm of other connective and soft tissue

6.01

6.32

1.9

1.1

1.82

3.83

ug/l

—

Disorders of conjunctiva

896

6019

1.20

6.22

1.3

3.42

3.76

ug/l

0.67

808

5433

Personality disorders, excluding more controls

240

3335

0.71

6.19

1.4

1.2

3.12

3.47

ug/l

0.89

219

3102

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

104

2.84

6.19

1.6

1.3

5.01

2.73

ug/l

0.33

Concussion

387

4104

0.77

6.15

1.3

4.14

3.88

ug/l

0.12

353

3749

Postpartum hemorraghe, all women as controls

648

5209

1.24

6.12

1.2

1.3

3.92

3.29

ug/l

0.50

605

4834

Disorders of adult personality and behaviour

262

3584

0.73

6.12

1.3

3.51

3.61

ug/l

0.08

238

3339

Carpal tunnel syndrome

202

2551

0.70

6.11

1.3

1.4

2.38

3.84

ug/l

2.96

157

2115

Other soft tissue disorders, not elsewhere classified

784

5536

0.83

6.05

1.3

3.03

3.82

ug/l

2.50

700

5057

Poisoning by drugs, medicaments and biological substances

165

2438

0.67

6.01

1.2

1.3

3.05

3.71

ug/l

1.66

149

2247

Personality disorders

240

3317

0.72

6.00

1.4

1.3

3.12

3.58

ug/l

1.17

219

3085

Other heart diseases

282

2499

0.73

5.99

1.3

2.40

3.94

ug/l

7.90

228

2229

Necrosis of pulp, including avohilmo

358

4659

0.76

5.97

1.3

3.60

3.68

ug/l

0.07

317

4172

Intestinal infectious diseases

933

5964

1.19

5.97

1.4

1.3

3.31

3.75

ug/l

1.50

838

5395

Insulin medication

204

2444

0.70

5.96

1.3

3.86

3.79

ug/l

0.05

177

2159

Other disorders involving the immune mechanism, not elsewhere classified

112

2.72

5.95

1.6

1.3

4.89

2.68

ug/l

0.34

Metabolic disorders

379

3012

0.77

5.94

1.7

1.4

2.52

4.02

ug/l

4.38

297

2564

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

135

2.52

5.92

2.2

1.1

1.92

2.32

ug/l

0.34

Gonarthrosis [arthrosis of knee](FG)

108

1021

0.61

5.84

1.8

1.6

4.28

4.60

ug/l

0.06

693

Emergency coronary revascularization (for ACS)

796

0.56

5.81

1.3

1.8

1.44

6.33

ug/l

3.00

508

Asthma, unspecified (mode), excluding more controls

307

3055

0.75

5.77

1.5

1.3

2.83

3.74

ug/l

3.45

278

2737

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

409

3140

1.29

5.76

1.5

1.4

2.93

3.75

ug/l

0.98

339

2732

Asthma, unspecified (mode)

307

3069

0.75

5.70

1.5

1.3

2.83

3.94

ug/l

3.19

278

2741

Codeine or tramadol medication

889

5760

0.84

5.63

1.4

1.3

3.70

3.54

ug/l

0.13

804

5207

Specific personality disorders

214

2977

0.71

5.61

1.3

3.08

3.62

ug/l

1.34

194

2776

Diabetic retinopathy, excluding more controls

609

0.52

5.60

1.3

1.4

3.58

5.25

ug/l

2.97

543

Melanocytic naevi of trunk

123

782

1.59

5.56

1.2

1.3

3.29

4.24

ug/l

0.90

103

725

Schizophrenia or delusion, excluding more controls

151

2209

0.67

5.52

1.5

1.3

3.69

3.67

ug/l

0.01

130

2017

Certain disorders involving the immune mechanism

104

635

1.65

5.51

1.7

1.4

5.08

3.70

ug/l

0.34

529

Major coronary heart disease event

846

0.58

5.49

1.7

1.79

6.06

ug/l

2.55

549

Dermatitis and eczema

1065

5656

1.17

5.44

1.3

3.36

3.71

ug/l

0.67

963

5090

Poisoning by medicine

154

2255

0.68

5.41

1.2

1.3

3.10

3.72

ug/l

1.38

140

2082

Artificial joint operation, meniscal resection

179

1670

0.69

5.41

1.7

1.5

4.21

4.44

ug/l

0.08

129

1300

Single delivery by forceps and vacuum extractor

433

2054

1.29

5.39

1.2

1.3

4.55

2.98

ug/l

1.44

410

1888

Fever of other and unknown origin

496

3542

1.25

5.38

1.5

1.3

3.42

3.90

ug/l

0.62

425

3196

Erysipelas

160

1783

0.68

5.36

1.4

3.89

4.30

ug/l

0.14

113

1480

Other other unspecified disorders of the circulatory system

3.57

5.33

2.2

1.8

2.63

5.12

ug/l

—

Disorders of lipoprotein metabolism and other lipidaemias

125

1189

0.65

5.31

1.7

1.5

2.91

5.14

ug/l

1.63

877

Coronary revascularization (ANGIO or CABG)

780

0.57

5.31

1.3

1.7

1.44

6.37

ug/l

2.98

502

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

306

4001

0.76

5.30

1.2

1.3

3.08

3.51

ug/l

1.35

283

3725

Examination and observation for other reasons

599

2824

1.23

5.29

1.4

1.3

3.25

4.06

ug/l

1.43

534

2568

Other bacterial intestinal infections

155

1048

1.49

5.27

1.4

1.3

3.51

4.14

ug/l

0.35

136

933

Percutaneous Coronary Intervention

779

0.57

5.26

1.3

1.7

1.44

6.37

ug/l

2.98

501

Malignant neoplasm of respiratory system and intrathoracic organs

3.06

5.24

1.8

1.1

2.66

2.79

ug/l

0.05

Disorders of choroid and retina

192

1920

0.71

5.21

1.6

1.4

7.46

3.96

ug/l

0.49

161

1588

Symptoms and signs involving the digestive system and abdomen

921

3915

1.18

5.16

1.4

1.3

4.31

3.79

ug/l

0.47

814

3567

Gonarthrosis

105

947

0.63

5.12

1.8

1.5

4.34

4.75

ug/l

0.08

675

Schizophrenia or delusion

151

2196

0.68

5.11

1.5

1.3

3.69

3.68

ug/l

0.00

130

1995

Schizophrenia, schizotypal and delusional disorders

151

2196

0.68

5.11

1.5

1.3

3.69

3.68

ug/l

0.00

130

1995

Malignant melanoma, including Hilmo

230

2.05

5.09

1.1

2.44

2.74

ug/l

0.32

194

Undescended testicle

13.53

5.09

2.0

1.0

14.21

39.02

ug/l

—

Malignant neoplasm of corpus uteri

3.76

5.08

2.1

1.1

0.54

1.82

ug/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

369

2883

1.28

5.05

1.4

2.92

3.80

ug/l

0.96

307

2497

Diabetes medication

713

5045

0.84

5.04

1.4

1.3

5.11

3.48

ug/l

7.80

642

4491

Intestinal stricture

573

1.64

5.03

1.2

1.5

1.78

4.60

ug/l

2.22

456

Other degenerative diseases of the nervous system

881

0.57

4.97

1.3

1.4

2.83

4.00

ug/l

1.03

764

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

306

3946

0.77

4.96

1.2

3.08

3.44

ug/l

1.16

283

3668

Dizziness and giddiness

359

3626

0.78

4.95

1.4

1.3

3.19

3.80

ug/l

1.17

303

3172

Implicit Sepsis

360

3355

0.78

4.95

1.5

1.3

3.55

4.01

ug/l

0.59

306

2963

Rheumatoid arthritis

1251

0.61

4.87

1.2

1.4

2.90

4.34

ug/l

1.17

1043

Conductive and sensorineural hearing loss

173

1649

0.71

4.82

1.6

1.4

3.72

4.65

ug/l

0.42

132

1325

Abdominal and pelvic pain

913

3915

1.17

4.79

1.3

4.41

3.79

ug/l

0.58

818

3567

Maternal care for other known or suspected fetal problems

640

3376

1.21

4.78

1.2

1.3

3.52

3.30

ug/l

0.60

603

3111

Insulin, fast-acting (human)

1145

0.58

4.76

1.3

4.40

3.81

ug/l

0.37

1067

Mental and behavioural disorders due to alcohol, excluding acute intoxication

122

1810

0.67

4.72

1.1

1.3

3.21

3.75

ug/l

0.67

108

1625

Other diseases of urinary system

1047

5096

1.16

4.67

1.3

3.46

3.68

ug/l

0.36

945

4598

Colorectal adenocarcinoma

3.01

4.64

1.9

1.1

3.06

2.54

ug/l

—

Diabetes mellitus

736

5078

0.85

4.62

1.4

1.3

5.01

3.49

ug/l

7.13

661

4527

Emotionally unstable personality disorder

142

2037

0.69

4.60

1.3

3.39

3.77

ug/l

0.53

129

1919

Cardiovascular diseases

889

5552

0.86

4.57

1.3

3.25

3.66

ug/l

1.16

803

5194

Schizophrenia

713

0.49

4.48

1.3

1.4

2.60

3.89

ug/l

1.11

632

Gonarthrosis,primary

870

0.63

4.47

1.9

1.7

5.16

5.24

ug/l

0.01

521

Dorsalgia

872

5429

0.86

4.47

1.3

3.33

3.68

ug/l

0.37

769

4973

Malignant neoplasm of rectum, including Hilmo

3.27

4.46

2.2

1.1

1.53

2.87

ug/l

—

Other disorders of adrenal gland

202

2.05

4.45

1.3

1.4

2.56

3.92

ug/l

0.61

183

Infections of genitourinary tract in pregnancy

100

1522

0.65

4.44

1.2

1.3

3.45

3.31

ug/l

0.15

1424

Varicose veins

1031

0.63

4.42

2.2

1.5

5.48

5.14

ug/l

0.04

723

Diabetic retinopathy

666

0.58

4.41

1.3

1.4

4.06

5.06

ug/l

0.85

589

Maternal care for known or suspected malpresentation of fetus

500

2980

1.23

4.40

1.3

3.51

3.14

ug/l

0.90

475

2750

Mood [affective] disorders

990

5569

1.15

4.40

1.3

3.01

3.75

ug/l

3.54

882

5017

Other bacterial intestinal infections

619

1.57

4.38

1.5

1.4

4.10

3.98

ug/l

0.04

544

Insulin, combination of fast acting with intermediate-acting or long-acting

204

2508

0.74

4.34

1.3

1.4

3.86

3.93

ug/l

0.06

177

2230

Malignant melanoma

190

2.06

4.33

1.1

2.69

2.74

ug/l

0.03

160

Parasetamol

936

4095

1.16

4.32

1.4

1.3

4.26

3.84

ug/l

0.37

850

3794

Mood disorders

990

5569

1.15

4.31

1.3

3.01

3.75

ug/l

3.54

882

5017

Migraine

792

5512

1.17

4.28

1.3

3.42

3.72

ug/l

0.54

723

5052

Diseases of pulp and periapical tissues, including avohilmo

892

5341

0.86

4.25

1.3

3.67

3.80

ug/l

0.19

810

4863

Other and unspecified tonsillitis

432

4438

0.81

4.23

1.3

3.36

3.59

ug/l

0.37

402

4192

Aplastic and other anaemias

158

1043

1.41

4.23

1.7

1.4

3.61

4.42

ug/l

0.41

128

867

Insulin, intermediate and long-acting

155

2103

0.71

4.22

1.3

1.4

3.82

4.09

ug/l

0.24

132

1856

Other surgical follow-up care

256

1.91

4.20

1.3

1.4

3.62

3.93

ug/l

0.18

240

L04AD Calcineurin inhibitors

417

1.69

4.19

1.6

1.5

3.47

4.81

ug/l

0.44

365

Other and unspecified iron deficiency

241

1832

1.32

4.17

1.3

4.06

3.94

ug/l

0.05

224

1618

Placenta praevia

116

786

1.51

4.13

1.2

1.3

2.73

3.25

ug/l

0.69

110

720

Other anaemias

140

928

1.44

4.11

1.6

1.4

3.75

4.37

ug/l

0.25

110

768

Other and unspecified nonorganic psychotic disorders

116

1692

0.68

4.11

1.5

1.3

3.84

3.79

ug/l

0.04

103

1562

Inguinal hernia

130

1251

0.69

4.10

1.3

3.83

4.09

ug/l

0.17

115

1120

Benign neoplasm of other and unspecified endocrine glands

412

1.68

4.10

1.3

1.5

2.29

4.11

ug/l

1.67

346

Colorectal cancer

119

2.30

4.09

1.6

1.1

2.57

2.55

ug/l

0.01

Malignant melanoma of skin, including Hilmo

196

2.00

4.01

1.1

2.44

2.70

ug/l

0.23

166

Iron deficiency anaemia

273

2093

1.29

4.00

1.3

1.4

3.92

3.85

ug/l

0.03

246

1837

Autoimmune diseases

1140

5106

1.14

3.99

1.3

3.51

3.89

ug/l

0.91

1039

4628

Reimbursement for rheumatic diseases

250

3212

0.77

3.99

1.3

1.4

3.40

3.86

ug/l

0.33

213

2777

Meniscus derangement

132

1268

0.70

3.97

1.2

1.4

2.55

4.27

ug/l

1.59

1007

Alcohol use disorder, ICD-based

119

1716

0.69

3.94

1.1

1.3

3.22

3.78

ug/l

0.67

105

1541

Diabetes, varying definitions

731

4984

0.86

3.89

1.4

1.3

5.04

3.49

ug/l

7.09

657

4437

Other and unspecified anaemias

137

918

1.42

3.87

1.7

1.4

3.78

4.38

ug/l

0.24

109

760

Anaemias

385

2035

1.24

3.87

1.3

1.2

3.76

3.55

ug/l

0.15

343

1946

Caries of dentine, including avohilmo

493

3029

0.83

3.85

1.4

1.3

4.32

4.02

ug/l

0.15

442

2703

Infections with a predominantly sexual mode of transmission

719

5773

1.17

3.82

1.2

1.3

3.33

3.41

ug/l

0.18

673

5370

Sub-endpoint used in defining T1D endpoints

135

1859

0.71

3.80

1.3

4.15

4.03

ug/l

0.08

123

1710

Benign neoplasm of bone and articular cartilage

422

1.65

3.79

1.8

1.4

5.41

3.87

ug/l

0.35

382

Benign neoplasm of other and unspecified female genital organs

175

2.02

3.70

1.6

1.5

2.24

4.69

ug/l

0.96

152

Antihypertensive medication - note that there are other indications

911

5507

0.87

3.68

1.3

3.21

3.63

ug/l

1.16

846

5113

Explicit Sepsis

240

1739

1.29

3.61

1.6

1.4

3.71

4.18

ug/l

0.29

198

1541

Substance use, excluding alcohol

1388

0.67

3.60

1.3

6.93

3.65

ug/l

0.43

1281

Bronchitis

1040

5792

1.13

3.58

1.3

3.25

3.72

ug/l

1.43

947

5212

Exposure to unspecified factor

747

6180

0.87

3.53

1.4

1.3

4.37

3.62

ug/l

0.72

672

5577

Allergic conjunctivitis

671

5641

1.16

3.53

1.3

3.56

3.68

ug/l

0.14

608

5069

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

645

5395

1.17

3.52

1.3

3.45

3.70

ug/l

0.36

588

4849

Rheumatoid arthritis, including avohilmo

107

1536

0.69

3.51

1.2

1.4

2.67

3.95

ug/l

1.82

1277

Intestinal adhesions without obstruction

131

2.15

3.51

1.3

1.8

2.04

5.80

ug/l

0.94

Diseases of middle ear and mastoid

803

5737

1.15

3.50

1.3

3.88

3.47

ug/l

0.48

745

5332

Nutritional anaemias

288

2215

1.26

3.48

1.3

1.4

3.86

3.81

ug/l

0.02

257

1923

Colectomy operation

272

1.77

3.48

1.9

1.6

4.76

4.09

ug/l

0.12

216

Schizoaffective disorder

517

0.48

3.46

1.2

1.3

3.08

3.90

ug/l

0.50

477

Bacterial intestinal infections, IBD co-morbidities

615

1.50

3.46

1.5

1.4

3.96

4.07

ug/l

0.03

538

Bipolar affective disorders

163

2175

0.75

3.44

1.2

1.3

2.88

3.71

ug/l

2.23

144

2021

174

2289

0.75

3.42

1.3

2.71

3.37

ug/l

2.30

166

2153

Rotator cuff syndrome

122

1226

0.71

3.39

1.5

2.43

4.82

ug/l

2.07

929

Depression medications

524

2221

1.19

3.38

1.3

1.2

3.39

3.56

ug/l

0.23

490

2129

Other congenital malformations

118

835

1.43

3.35

1.6

1.3

5.52

4.11

ug/l

0.49

109

781

General symptoms and signs

1115

4975

1.12

3.33

1.4

1.3

3.81

3.72

ug/l

0.09

993

4519

Disorders of eyelid, lacrimal system and orbit

456

4113

0.84

3.32

1.3

1.4

2.93

3.73

ug/l

1.35

379

3613

Candidiasis

331

2703

1.23

3.31

1.3

3.27

3.65

ug/l

0.71

310

2470

Other retinal disorders

140

1486

0.73

3.31

1.5

1.4

4.36

4.03

ug/l

0.15

114

1242

Complications of medical and surgical care

519

4054

1.18

3.31

1.4

1.3

2.83

3.65

ug/l

1.38

428

3559

L01XE Protein kinase inhibitors

2.93

3.30

1.2

1.5

12.18

2.97

ug/l

—

Foreign body on external eye

438

1.58

3.29

1.3

3.16

3.72

ug/l

0.55

401

Other disorders of the genitourinary system

233

1.81

3.28

1.6

1.7

5.97

4.99

ug/l

0.08

170

Other coagulation defects

511

1.54

3.27

1.7

1.4

2.95

4.17

ug/l

0.97

472

Acute tubulo-interstitial nephritis

404

4172

0.83

3.27

1.3

3.71

3.85

ug/l

0.12

342

3772

Codeine

865

5328

0.88

3.23

1.4

1.3

3.75

3.60

ug/l

0.12

784

4873

Other complications of surgical and medical care, not elsewhere classified

496

1.54

3.23

1.9

1.4

5.35

3.77

ug/l

0.35

442

Triptan medication for migraine, min. 3 purchases

870

5866

1.14

3.21

1.3

3.22

3.63

ug/l

1.07

790

5354

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

3.54

3.19

1.4

1.1

0.80

2.90

ug/l

—

Sensorineural hearing loss

141

1296

0.74

3.17

1.5

2.39

5.12

ug/l

2.97

101

1000

Malignant neoplasm of digestive organs

196

1.77

3.13

1.5

1.1

2.34

2.52

ug/l

0.08

132

Alcohol dependence

627

0.56

3.08

1.2

1.4

3.24

3.97

ug/l

0.32

551

Preterm labour and delivery

282

2284

1.24

3.08

1.4

1.3

3.77

3.61

ug/l

0.14

258

1978

Seropositive rheumatoid arthritis

858

0.63

3.03

1.1

1.5

3.18

4.29

ug/l

0.60

680

Motor disorders

126

2.10

3.02

1.7

1.5

5.80

7.46

ug/l

0.30

118

Other and unspecified immunodeficiencies with predominantly antibody defects

2.80

3.01

2.7

1.3

16.04

3.40

ug/l

0.65

Specific developmental disorder of motor function

124

2.09

3.00

1.7

1.5

5.80

8.16

ug/l

0.44

118

Endometriosis in cutaneous scar

10.33

3.00

1.2

1.0

3.79

1.41

ug/l

—

Type 1 diabetes, wide definition, subgroup 1

121

1648

0.73

3.00

1.3

4.09

3.93

ug/l

0.12

111

1516

Family history of certain disabilities and chronic diseases leading to disablement

605

1.47

2.99

1.4

1.3

2.90

3.65

ug/l

1.24

569

Leiomyosarcoma

10.16

2.99

1.0

1.2

—

0.59

—

ILD medications: immunosuppressive drugs

397

4376

0.84

2.97

1.4

1.3

2.94

3.87

ug/l

2.17

347

3882

Viral infections characterized by skin and mucous membrane lesions

808

6114

1.13

2.94

1.3

3.97

3.69

ug/l

0.24

716

5529

Type 1 diabetes, wide definition

124

1677

0.74

2.94

1.2

1.3

4.38

3.91

ug/l

0.37

113

1542

Acute upper respiratory infections

951

5224

1.12

2.93

1.3

3.38

3.75

ug/l

0.82

852

4689

Heart failure, not strict

104

988

0.71

2.92

1.8

1.6

11.70

4.52

ug/l

0.32

724

Periapical abscess

168

2176

0.77

2.89

1.7

1.4

3.26

4.00

ug/l

0.88

147

1890

Haemorrhage from respiratory passages

126

833

1.37

2.88

1.5

1.6

4.07

5.02

ug/l

0.33

105

701

Leiomyosarcoma, including Hilmo

6.76

2.88

1.0

1.1

—

0.97

—

Insulin, fast-acting or short human

147

1935

0.76

2.88

1.3

4.16

3.98

ug/l

0.13

128

1751

Motor disorders, excluding more controls

122

2.06

2.87

1.7

1.4

5.80

7.86

ug/l

0.39

117

Exposure to other specified factors

551

5830

0.87

2.86

1.3

3.63

3.78

ug/l

0.17

504

5275

Malignant neoplasm of eye, brain and central nervous system

109

2.12

2.85

1.7

1.1

2.89

3.02

ug/l

0.06

Pure hypercholesterolaemia

101

923

0.71

2.84

1.7

1.6

3.45

5.46

ug/l

0.98

660

Other embolism and thrombosis

336

1.61

2.84

1.4

1.5

2.50

4.23

ug/l

1.12

284

Coxarthrosis

457

0.59

2.84

1.3

1.7

2.65

7.66

ug/l

1.19

273

Need for immunization against other single viral diseases

2.80

2.83

1.8

1.3

2.81

3.24

ug/l

0.16

Other skin changes

594

1.45

2.82

1.3

1.4

2.39

4.13

ug/l

2.64

522

Iron deficiency anaemia secondary to blood loss (chronic)

408

1.55

2.81

1.6

1.5

4.68

3.97

ug/l

0.10

340

Adenocarcinoma and papilloma adenocarcinoma of rectum

3.34

2.80

1.5

1.1

0.80

3.02

ug/l

—

Injuries to the elbow and forearm

468

4792

0.86

2.80

1.4

1.3

3.25

4.08

ug/l

2.70

418

4295

Adalimumab

694

0.60

2.79

1.2

1.3

3.10

3.92

ug/l

0.82

634

Insulin, fast-acting

147

1925

0.76

2.78

1.3

4.16

4.00

ug/l

0.12

128

1742

Maternal care for known or suspected abnormality of pelvic organs

535

3149

1.16

2.78

1.2

1.3

3.47

3.23

ug/l

0.70

504

2868

Type 1 diabetes

136

1797

0.75

2.77

1.3

4.12

3.90

ug/l

0.16

124

1643

Other pleural conditions

2.37

2.72

2.0

1.6

2.23

4.91

ug/l

0.68

Asthma (diagnoses ohter than nonallergic)

650

6123

0.88

2.71

1.4

1.3

3.38

3.77

ug/l

0.66

585

5516

Dental caries

175

1309

1.29

2.71

1.5

1.3

3.91

4.66

ug/l

0.29

146

1178

Voice disturbances

151

1153

1.31

2.70

1.5

1.4

3.08

3.99

ug/l

0.48

124

973

Myeloid leukaemia

3.02

2.70

1.3

1.6

2.75

3.25

ug/l

—

Enterocolitis due to Clostridium difficile

265

1.67

2.65

1.9

1.4

2.48

4.08

ug/l

0.79

226

Seropositive rheumatoid arthritis, wide

832

0.65

2.65

1.1

1.5

3.18

4.42

ug/l

0.67

673

Constipation

384

3135

0.85

2.64

1.4

3.47

4.15

ug/l

0.75

309

2689

Other/unspecified seropositive rheumatoid arthritis

819

0.65

2.63

1.2

1.5

3.22

4.46

ug/l

0.66

660

Pseudohypoparathyroidism

8.08

2.63

1.2

1.1

2.63

5.89

ug/l

—

Other nutritional deficiencies

713

5950

1.13

2.63

1.3

3.53

3.60

ug/l

0.11

652

5381

Maternal care for known or suspected disproportion

427

0.51

2.63

2.4

1.3

5.52

2.79

ug/l

0.42

365

Complications predominantly related to the puerperium

476

4116

1.16

2.61

1.2

1.3

3.32

3.43

ug/l

0.21

451

3774

Cholecystectomy

296

3070

0.83

2.60

1.3

1.4

2.88

3.70

ug/l

1.36

233

2592

Presence of other functional implants

595

0.65

2.60

2.7

1.7

20.31

5.83

ug/l

0.41

399

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

815

0.65

2.58

1.2

1.5

3.22

4.47

ug/l

0.67

657

Disorders of refraction and accommodation

303

2515

1.20

2.57

1.4

1.3

4.00

4.04

ug/l

0.03

279

2308

Disorders of synovium and tendon

342

3549

0.84

2.56

1.3

3.19

3.71

ug/l

0.62

294

3148

Effects of foreign body entering through natural orifice

147

1128

1.31

2.56

1.3

3.70

4.29

ug/l

0.49

134

1026

Malignant melanoma of skin

156

1.86

2.56

1.1

2.72

2.76

ug/l

0.02

131

Coxarthrosis [arthrosis of hip](FG)

498

0.62

2.55

1.5

1.8

3.34

7.47

ug/l

0.89

280

Coagulation defects, purpura and other haemorrhagic conditions

149

1147

1.30

2.55

1.5

1.4

3.38

4.07

ug/l

0.67

135

1028

Hallux valgus (acquired)

852

0.71

2.55

1.8

1.5

2.30

5.03

ug/l

1.68

642

Artificial opening status

2.14

2.55

1.2

1.5

2.41

3.66

ug/l

1.13

Acute posthaemorrhagic anaemia

2.43

2.54

1.5

1.4

2.88

3.40

ug/l

0.23

Dermatophytosis

447

3846

1.16

2.54

1.3

2.94

3.59

ug/l

2.83

399

3432

STROKE

107

987

0.74

2.53

1.9

1.5

3.80

5.53

ug/l

0.55

743

Hypermetropia

460

1.49

2.52

1.5

1.4

3.69

4.92

ug/l

0.93

427

Scabies

104

1406

0.74

2.52

1.2

1.3

3.27

4.09

ug/l

1.18

1310

Other disorders of lacrimal gland

216

1744

1.24

2.49

1.3

1.4

2.42

3.92

ug/l

3.49

178

1494

Other medical care

210

1517

1.25

2.49

1.8

1.4

4.79

4.07

ug/l

0.16

166

1301

Zoster [herpes zoster]

240

1928

1.23

2.49

1.5

1.4

3.39

3.82

ug/l

0.25

203

1642

Malignant neoplasm of rectum

2.98

2.48

1.5

1.1

0.80

2.73

ug/l

—

Autoimmune diseases related-to ILD

601

5828

0.88

2.48

1.3

3.01

3.72

ug/l

1.78

530

5235

Astigmatism

462

1.48

2.47

1.5

1.4

4.01

4.70

ug/l

0.35

429

Other female pelvic inflammatory diseases

150

1162

1.30

2.47

1.4

1.3

2.52

4.05

ug/l

2.27

129

1015

Implicit Sepsis

296

2672

0.83

2.47

1.5

1.4

3.74

4.18

ug/l

0.42

250

2345

Delivery

511

2338

1.16

2.47

1.3

4.79

3.24

ug/l

2.38

480

2087

Diseases of arteries, arterioles and capillaries

100

1005

0.73

2.44

1.8

1.5

2.88

4.57

ug/l

1.49

799

Disorders of lens

655

0.69

2.44

1.6

1.7

26.88

4.38

ug/l

0.72

428

Other problems related to primary support group, including family circumstances

191

1487

1.26

2.43

1.5

1.3

4.31

4.20

ug/l

0.06

175

1389

Dental caries, including avohilmo

424

2526

0.86

2.43

1.4

1.3

3.43

3.97

ug/l

0.59

378

2233

Bacterial infection, other or unspecified

208

1453

1.24

2.42

1.5

1.4

3.23

4.29

ug/l

0.85

166

1232

Caries of dentine

146

1098

1.30

2.42

1.4

1.3

3.73

4.32

ug/l

0.23

121

997

Colonic or urogenital fistula

144

1112

1.30

2.41

1.3

1.4

2.90

3.97

ug/l

1.28

126

961

Injuries to the wrist and hand

793

6123

0.90

2.41

1.3

3.62

3.72

ug/l

0.11

728

5516

Other symptoms and signs involving the nervous and musculoskeletal systems

223

2726

0.82

2.40

1.3

3.50

3.81

ug/l

0.20

190

2426

Paralytic ileus and intestinal obstruction

490

1.45

2.38

1.2

1.6

1.63

5.07

ug/l

2.38

388

Diseases of the musculoskeletal system and connective tissue

706

3977

0.89

2.37

1.3

3.79

4.07

ug/l

0.21

648

3698

Melanocytic naevi of other and unspecified parts of face

354

1.54

2.36

1.3

1.4

3.00

4.14

ug/l

0.73

326

L04AX Other immunosuppressants

290

3448

0.84

2.33

1.4

3.06

3.93

ug/l

1.33

257

3016

Other neurological diseases

223

2139

0.82

2.32

1.6

1.4

3.44

4.21

ug/l

0.48

175

1808

Gastro-oesophageal reflux disease

281

2891

0.84

2.30

1.4

3.96

3.86

ug/l

0.04

235

2463

Other dorsopathies, not elsewhere classified

942

5438

0.91

2.28

1.3

3.41

3.72

ug/l

0.34

843

4982

Zoster [herpes zoster]

504

1.43

2.27

1.6

1.4

2.45

4.35

ug/l

2.25

430

Other CVD

246

1.63

2.26

1.7

1.6

2.66

4.45

ug/l

0.83

193

Malignant neoplasm of colon, including Hilmo

2.02

2.25

1.8

1.1

2.74

2.62

ug/l

0.03

Second line medication for Crohn's disease

318

3737

0.85

2.24

1.4

1.3

3.03

3.88

ug/l

1.48

285

3288

Oxicams

102

777

0.74

2.24

1.3

2.09

4.02

ug/l

1.69

713

Biological medication for rheuma

107

1413

0.75

2.24

1.2

1.3

2.98

3.98

ug/l

1.44

1286

Viral warts

229

1887

1.22

2.24

1.3

4.92

3.77

ug/l

0.38

213

1729

Other joint disorders

950

5517

0.91

2.23

1.3

3.62

3.73

ug/l

0.10

850

5075

Persistent mood disorders

101

1343

0.75

2.22

1.2

1.3

2.72

4.03

ug/l

2.41

1215

Temporomandibular joint disorders, including avohilmo

663

5850

1.12

2.18

1.3

2.90

3.55

ug/l

2.50

612

5362

Family history of other conditions

144

1.84

2.18

1.4

1.2

2.13

3.23

ug/l

2.26

134

Supplementary factors related to causes of morbidity and mortality classified elsewhere

162

2023

0.80

2.17

1.7

1.3

5.53

3.70

ug/l

0.41

143

1835

Acute alcohol intoxication

1073

0.73

2.15

1.3

3.35

4.03

ug/l

0.83

987

Vulvovaginal ulceration/inflammation in other diseases

120

925

1.31

2.14

1.4

1.3

2.60

3.89

ug/l

2.33

109

866

Injuries to the thorax

128

1640

0.78

2.14

1.8

1.4

5.86

3.84

ug/l

0.36

115

1439

Thrombocytopenia, unspecified

212

1.66

2.13

1.4

3.61

4.00

ug/l

0.13

189

Other diseases of intestine

212

1.65

2.12

1.4

1.7

2.14

5.48

ug/l

1.36

159

Arthropathies

995

5524

0.91

2.12

1.3

3.60

3.77

ug/l

0.18

899

5081

Postpartum haemorrhage due to retained placenta

283

2398

1.19

2.11

1.2

1.3

3.20

3.84

ug/l

1.53

262

2245

COPD/asthma/ILD related infections

881

4860

0.91

2.10

1.3

3.32

3.75

ug/l

0.98

779

4387

COPD/asthma related infections

881

4860

0.91

2.10

1.3

3.32

3.75

ug/l

0.98

779

4387

Other specified/unspecified arthritis

122

1568

0.78

2.09

1.4

1.3

5.89

3.84

ug/l

0.70

108

1367

Acute alcohol intoxication, ICD10

1043

0.73

2.08

1.3

3.37

4.35

ug/l

1.09

972

Candidiasis

119

918

1.30

2.08

1.3

2.54

3.66

ug/l

2.38

110

831

Diseases of pulp and periapical tissues and dental caries

396

2342

0.86

2.08

1.4

1.3

3.51

3.93

ug/l

0.38

351

2077

Malignant neoplasm of endocrine gland

237

1.61

2.07

1.4

1.2

1.96

2.69

ug/l

0.67

209

Persons encountering health services in other circumstances

392

3389

1.15

2.06

1.3

3.39

3.81

ug/l

0.89

356

3112

Fracture of lower leg, including ankle

236

2792

0.84

2.05

1.7

1.4

4.66

4.05

ug/l

0.31

206

2440

Other obstetric trauma

114

879

1.31

2.05

1.2

1.3

3.34

3.88

ug/l

0.49

108

810

Oxycodone

673

1.33

2.04

1.7

1.5

4.17

4.26

ug/l

0.02

512

Carcinoma in situ of breast, intraductal

162

1.73

2.01

1.9

2.0

18.93

6.50

ug/l

0.32

111

Right hemicolectomy

2.51

2.01

3.5

1.2

15.17

2.25

ug/l

—

Thyrotoxicosis with diffuse goitre

129

1011

1.28

2.01

1.2

1.3

2.37

3.75

ug/l

2.44

112

890

Hernia of abdominal wall, postoperative

475

1.41

2.01

2.4

1.2

2.23

3.00

ug/l

1.22

407

Pediculosis, acariasis and other infestations

118

1511

0.78

2.00

1.2

1.3

3.20

4.01

ug/l

1.29

106

1403

Crossbite

541

1.38

2.00

1.7

1.4

5.29

5.35

ug/l

0.01

503

Benign neoplasm: Brain, infratentorial

3.41

1.98

1.7

1.5

2.34

2.24

ug/l

—

Dorsopathies

983

5456

0.91

1.97

1.3

3.63

3.80

ug/l

0.17

890

4999

Benign neoplasm: Colon, unspecified

217

1.61

1.96

1.5

1.8

3.25

5.42

ug/l

0.57

140

All dysplastic lesions of the vagina

149

1.76

1.96

1.4

1.5

2.07

4.84

ug/l

0.92

130

Mood disorders, excluding more controls

833

4518

1.10

1.94

1.3

3.04

3.70

ug/l

2.40

734

4055

Coronary atherosclerosis

403

0.66

1.93

2.3

2.0

2.80

9.51

ug/l

1.25

213

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

570

0.64

1.93

1.3

3.50

3.55

ug/l

0.03

541

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

363

1.47

1.93

2.0

1.4

3.01

4.23

ug/l

0.77

319

Open wound of wrist and hand

277

3170

0.85

1.92

1.3

3.56

3.71

ug/l

0.11

254

2914

Thyrotoxicosis, other and/or unspecified

164

1331

1.24

1.91

1.2

1.4

2.48

3.97

ug/l

2.63

142

1177

Malignant neoplasm of colon

2.05

1.90

1.8

1.1

3.37

2.85

ug/l

0.11

Other congenital malformations

158

1278

1.24

1.90

1.5

1.3

4.61

4.31

ug/l

0.10

148

1185

Disorders of lacrimal system

254

2144

1.18

1.90

1.3

1.4

2.58

4.15

ug/l

3.05

210

1838

Diseases of peritoneum

243

1.57

1.89

1.4

1.5

1.79

4.05

ug/l

1.31

204

Type of accident

146

1808

0.81

1.86

1.7

1.3

5.64

3.74

ug/l

0.38

128

1638

Cyst of kidney

2.09

1.86

1.0

1.5

3.55

2.68

ug/l

—

Viral infections characterized by skin and mucous membrane lesions

305

2626

1.16

1.84

1.4

1.3

4.02

3.87

ug/l

0.05

265

2359

Bleeding

264

2203

0.85

1.83

1.4

3.75

4.46

ug/l

0.47

221

1863

Bacterial pneumoniae

134

1475

0.80

1.83

1.5

1.4

2.82

4.28

ug/l

2.39

116

1304

Gonarthrosis, primary, with knee surgery

343

0.60

1.82

3.3

2.2

18.17

15.22

ug/l

—

111

Other arthrosis

827

0.76

1.81

1.5

1.92

4.95

ug/l

1.74

578

Melanocytic naevi, other sites/unspecified

486

1.39

1.81

1.3

2.48

3.81

ug/l

1.36

444

Disorders of breast

441

4515

0.88

1.81

1.4

1.3

3.78

3.51

ug/l

0.10

369

3995

Other chronic obstructive pulmonary disease, including avohilmo

475

0.66

1.79

1.1

1.8

3.73

5.42

ug/l

0.50

317

Tumor necrosis factor alpha inhibitors

100

1286

0.77

1.79

1.2

1.3

3.03

4.04

ug/l

1.33

1177

Problems related to lifestyle

865

0.72

1.79

1.4

1.3

3.00

3.79

ug/l

0.82

816

Haemorrhoids and perianal venous thrombosis

136

1088

1.25

1.77

1.3

1.5

3.32

4.29

ug/l

0.79

125

932

Childhood allergy (age < 16)

348

3273

0.87

1.76

1.2

1.3

4.42

4.09

ug/l

0.37

333

3165

Other arthritis (FG)

143

1762

0.81

1.76

1.4

5.40

3.96

ug/l

0.53

128

1517

Benign neoplasm of other and ill-defined parts of digestive system

362

1.44

1.76

1.5

3.64

4.29

ug/l

0.26

288

Type 2 diabetes

643

4154

0.90

1.75

1.4

1.3

5.18

3.40

ug/l

7.48

575

3647

Personal history of other diseases and conditions

190

1576

1.21

1.75

1.4

1.3

4.36

4.09

ug/l

0.13

177

1484

Abnormal findings on diagnostic imaging of other body structures

404

1.41

1.75

2.1

1.5

3.67

4.10

ug/l

0.12

341

Medical observation and evaluation for suspected diseases and conditions

614

2824

1.11

1.75

1.4

1.3

3.35

4.06

ug/l

0.85

550

2568

Other disorders of central nervous system

2.25

1.75

1.3

1.4

2.14

3.36

ug/l

—

Duodenal ulcer

2.13

1.71

1.2

1.6

2.40

3.13

ug/l

—

Superficial injury of lower leg

161

1952

0.82

1.71

1.3

3.48

3.78

ug/l

0.41

137

1786

Cerebrovascular diseases

111

988

0.79

1.70

1.8

1.6

4.05

5.15

ug/l

0.33

734

Infections of the skin and subcutaneous tissue

385

4315

0.88

1.69

1.3

3.09

3.79

ug/l

2.25

343

3915

Other postsurgical states

179

1.63

1.69

1.4

1.6

1.53

3.34

ug/l

1.61

157

Other chronic obstructive pulmonary disease

337

0.61

1.69

1.2

1.9

2.97

6.78

ug/l

1.04

224

Acute sinusitis

470

4862

0.89

1.67

1.3

3.64

3.63

ug/l

0.01

417

4421

Olecranon bursitis

2.59

1.66

1.4

2.30

2.24

ug/l

—

Other maltreatment syndromes

147

0.41

1.64

1.8

1.3

1.78

2.86

ug/l

—

134

Other puerperal infections

220

1874

1.19

1.64

1.2

1.3

3.07

3.52

ug/l

0.90

208

1769

COPD

361

0.63

1.63

1.2

1.9

2.68

6.50

ug/l

1.18

241

Malignant neoplasm of thyroid gland, including Hilmo

253

1.51

1.63

1.4

1.2

1.75

2.82

ug/l

2.20

223

Dislocation, sprain and strain of joints and ligaments of knee

478

4908

0.90

1.62

1.4

1.3

3.95

3.63

ug/l

0.31

424

4443

Other inflammation of vagina/vulva

515

1.36

1.62

1.2

1.3

2.54

3.19

ug/l

0.99

480

Thyroiditis, ILD-related definition

124

998

1.25

1.62

1.4

1.3

3.78

4.00

ug/l

0.07

110

907

Excessive attrition of teeth

563

5094

1.11

1.61

1.3

3.61

3.71

ug/l

0.09

505

4600

Organic, including symptomatic, mental disorders

391

0.67

1.60

2.3

1.8

2.85

5.87

ug/l

1.08

279

Ischaemic heart disease, wide definition

599

0.75

1.58

1.9

1.8

1.97

7.40

ug/l

1.88

351

Other specified and unspecified personality disorders

799

0.73

1.58

1.3

3.83

4.24

ug/l

0.22

738

Injuries to the hip and thigh

136

1504

0.82

1.56

1.4

3.91

4.35

ug/l

0.18

118

1303

Other condition

786

0.74

1.55

1.4

4.54

4.01

ug/l

0.14

717

Nonischemic cardiomyopathy

1.85

1.55

1.1

1.6

1.58

3.81

ug/l

—

Seborrhoeic keratosis

297

1.45

1.54

1.3

1.6

2.65

5.66

ug/l

0.79

206

Erysipelas

100

1116

0.79

1.54

1.4

1.5

2.40

4.39

ug/l

2.43

902

Other and unspecified drugs and medicaments

398

1.39

1.54

1.4

2.60

4.05

ug/l

1.24

357

Other and unspecified mood [affective] disorders

1033

0.77

1.54

1.5

1.3

3.40

4.23

ug/l

0.89

980

Viral haemorrhagic fevers, not elsewhere classified/unspecified

771

1.27

1.54

1.4

3.26

4.64

ug/l

1.26

695

Diabetic retinopathy, strict definition

633

0.72

1.54

1.3

1.4

4.17

5.06

ug/l

0.62

582

Falls/tendency to fall

1038

5595

0.93

1.54

1.3

3.39

3.73

ug/l

0.72

926

5080

Soft tissue disorders

1000

5547

0.93

1.53

1.3

3.24

3.85

ug/l

1.81

907

5068

Obesity related asthma

125

1534

0.81

1.52

1.3

1.4

4.05

4.16

ug/l

0.04

105

1300

Other disorders of the musculoskeletal system and connective tissue

371

0.62

1.52

1.3

1.5

2.07

4.09

ug/l

1.37

303

Exposure to other specified electric current

184

0.48

1.51

1.0

1.4

2.97

2.93

ug/l

—

169

Internal derangement of knee

190

2229

0.85

1.51

1.3

3.18

3.95

ug/l

0.77

163

1972

Misadventures to patients during surgical and medical care

599

1.31

1.49

1.4

2.10

3.87

ug/l

2.69

527

Stroke, including SAH

627

0.75

1.49

2.1

1.7

5.11

4.86

ug/l

0.04

442

Iron deficiency

498

1.35

1.48

1.3

2.75

3.38

ug/l

1.24

472

Sciatica+with lumbago

278

2926

0.87

1.48

1.3

1.4

3.09

3.64

ug/l

0.54

234

2567

Polyneuropathies and other disorders of the peripheral nervous system

325

1.42

1.48

2.2

1.5

5.30

3.95

ug/l

0.22

257

Placental disorders

156

1.65

1.48

1.2

1.4

3.15

2.84

ug/l

0.26

143

Other external causes of accidental injury

788

4284

0.92

1.46

1.3

4.04

3.69

ug/l

0.30

706

3877

Other follicular disorders

569

0.70

1.46

1.2

1.3

3.05

3.65

ug/l

0.42

532

Obstructive hydrocephalus

2.39

1.46

1.9

1.2

3.47

3.63

ug/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

413

4545

0.89

1.45

1.3

3.43

3.56

ug/l

0.17

381

4223

Fenamates

169

960

1.20

1.45

1.3

4.97

3.92

ug/l

0.18

154

890

Any death

526

0.73

1.45

1.9

1.8

4.94

5.03

ug/l

0.01

342

Fissure and fistula of anal and rectal regions

134

1102

1.22

1.45

1.2

1.4

2.89

4.31

ug/l

1.43

117

958

Mental and behavioural disorders due to opioids

340

0.61

1.44

1.3

1.2

2.82

3.44

ug/l

0.42

320

Appendicitis, broad definition

541

5377

0.91

1.44

1.4

1.3

4.24

3.43

ug/l

0.43

475

4828

Abnormal findings on antenatal screening of mother

197

2295

0.85

1.43

1.2

3.04

3.20

ug/l

0.32

182

2175

COPD, early/later onset

329

0.64

1.43

1.2

1.8

2.97

5.93

ug/l

0.75

222

Anomalies of dental arch relationship, including avohilmo

243

1900

1.16

1.42

1.5

1.3

4.15

4.13

ug/l

0.01

220

1766

Acetic acid derivatives and related substances

278

1256

1.15

1.42

1.3

1.2

5.48

4.10

ug/l

0.45

262

1173

Pain in joint

537

3106

1.10

1.42

1.3

3.64

3.91

ug/l

0.16

471

2838

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

214

2483

0.86

1.42

1.3

3.19

3.74

ug/l

0.77

195

2260

Hyperhidrosis

304

1.43

1.41

1.2

1.3

3.22

3.87

ug/l

0.46

285

Antepartum haemorrhage, not elsewhere classified

185

1576

1.18

1.41

1.2

1.3

4.80

3.12

ug/l

0.47

168

1448

Spondylosis

898

0.79

1.41

1.6

3.87

5.03

ug/l

0.20

638

Diseases of appendix

544

5379

0.91

1.40

1.4

1.3

4.22

3.43

ug/l

0.42

478

4828

Symptoms and signs involving speech and voice

165

1390

1.19

1.39

1.4

3.09

3.85

ug/l

0.44

137

1172

Bacterial pneumonia, not elsewhere classified

127

1356

0.82

1.39

1.6

1.4

2.93

4.37

ug/l

2.06

109

1194

Localized swelling, mass and lump of skin and subcutaneous tissue

183

1556

1.18

1.39

1.4

3.15

4.03

ug/l

0.81

159

1368

Tooth agenesis EXCLUDE clefts and syndromes

520

1.32

1.39

1.3

4.73

4.21

ug/l

0.12

492

Other viral diseases, not elsewhere classified

156

1305

1.20

1.39

1.3

3.58

4.37

ug/l

0.87

137

1190

COPD, hospital admissions

327

0.65

1.38

1.2

1.8

2.97

5.95

ug/l

0.75

221

Soft tissue disorders related to use, overuse and pressure

793

0.76

1.38

1.3

1.5

4.89

4.53

ug/l

0.06

633

Childhood asthma (age<16), excluding more controls

285

2547

0.88

1.38

1.2

1.3

3.58

3.78

ug/l

0.31

271

2453

Fibromyalgia

746

0.75

1.38

1.3

2.09

3.50

ug/l

2.55

661

Mycoses

169

1429

1.19

1.38

1.3

4.31

3.56

ug/l

0.15

151

1272

Hypertrophy of tongue papillae

2.22

1.37

1.2

2.53

2.95

ug/l

—

Focal epilepsy

1072

0.79

1.37

1.2

1.4

2.79

4.50

ug/l

2.52

965

Secondary thrombocytopenia

2.63

1.37

1.3

1.1

5.57

4.69

ug/l

—

Other systemic involvement of connective tissue (FG)

115

1385

0.82

1.36

1.2

1.4

2.51

3.99

ug/l

2.42

1183

Benign paroxysmal vertigo

111

902

1.23

1.36

1.3

1.5

2.72

4.27

ug/l

1.56

732

Accidents

791

4284

0.92

1.36

1.3

4.03

3.69

ug/l

0.29

709

3877

Bacterial infection, other or unspecified

236

1731

1.15

1.36

1.4

3.25

4.10

ug/l

0.78

189

1491

Epilepsy

147

1746

0.84

1.36

1.3

3.17

4.34

ug/l

1.99

127

1570

Malignant neoplasm of skin

354

1.32

1.35

1.3

1.1

2.97

2.66

ug/l

0.25

260

Depression or dysthymia

503

2516

1.10

1.34

1.3

3.60

4.06

ug/l

0.27

444

2239

Other and unspecified nerve root and plexus disorders, also in other diseases

845

0.77

1.34

1.4

5.60

3.94

ug/l

0.45

727

Arthropod-borne viral fevers and viral haemorrhagic fevers

104

841

1.24

1.34

1.4

3.12

4.52

ug/l

1.45

758

Atrophic disorders of skin

663

1.27

1.34

1.3

1.4

2.78

3.88

ug/l

1.28

571

Diaphragmatic hernia

672

1.27

1.33

1.4

1.6

2.68

4.61

ug/l

1.34

500

Childhood asthma (age<16)

286

2549

0.88

1.33

1.2

1.3

3.74

3.78

ug/l

0.05

272

2453

Ventral hernia

593

1.28

1.32

2.8

1.4

3.25

4.74

ug/l

0.55

483

Symptoms and signs involving the urinary system

300

2581

0.88

1.32

1.4

3.62

4.20

ug/l

0.44

259

2222

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

101

1240

0.81

1.32

1.3

3.02

3.97

ug/l

1.50

1159

Alcohol abuse, main dg, excluding more controls

820

0.77

1.32

1.3

3.11

4.14

ug/l

1.33

761

Other congenital malformations of tongue, mouth and pharynx

192

0.51

1.31

1.5

1.4

3.74

5.45

ug/l

—

179

Diverticular disease of intestine

755

0.80

1.31

1.4

1.7

2.25

5.98

ug/l

1.82

495

Nausea and vomiting

205

1733

1.16

1.31

1.4

1.3

3.61

3.85

ug/l

0.14

180

1591

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

463

1.32

1.31

1.4

2.69

4.35

ug/l

1.59

421

Other bacterial diseases

449

3333

0.90

1.31

1.5

1.4

3.28

4.14

ug/l

1.12

351

2904

Striking against or struck by other objects

207

2387

0.86

1.30

1.3

3.43

3.99

ug/l

0.78

194

2198

Osteoporosis

336

1.36

1.29

1.7

1.8

3.16

6.07

ug/l

0.78

223

923

5112

0.93

1.29

1.3

3.31

3.74

ug/l

1.06

822

4596

Cerebrovascular diseases (FINNGEN)

723

0.79

1.28

2.0

1.4

4.43

3.71

ug/l

0.20

577

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

310

1.39

1.28

1.4

2.12

3.93

ug/l

1.36

275

Haemangioma, any site

344

1.37

1.28

1.4

1.5

2.73

4.34

ug/l

0.99

303

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

115

948

1.22

1.28

1.3

3.79

3.26

ug/l

0.19

100

849

Emotional disorders and disorders of social functioning with onset specific to childhood

1007

0.79

1.27

1.4

1.3

4.20

4.48

ug/l

0.25

967

Benign neoplasm: Colon

645

1.26

1.27

1.4

1.7

10.31

5.65

ug/l

0.28

434

COPD (mode)

250

0.63

1.26

1.2

2.0

2.91

7.92

ug/l

1.06

164

Disorders of ocular muscles, binocular movement, accommodation and refraction

487

4402

1.10

1.26

1.3

4.05

3.88

ug/l

0.15

444

4016

Eating disorders

244

2141

1.14

1.26

1.4

1.3

4.23

3.68

ug/l

0.40

236

2038

Other disorders of fluid, electrolyte and acid-base balance

569

1.27

1.25

1.4

1.5

2.29

4.91

ug/l

1.83

444

Urticaria

322

2876

1.12

1.25

1.3

3.02

3.82

ug/l

2.29

292

2617

Eating disorder

239

2097

1.15

1.25

1.3

3.82

3.77

ug/l

0.04

231

1998

Coxarthrosis, primary

418

0.71

1.23

2.1

2.0

3.33

10.56

ug/l

1.19

194

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

103

1252

0.82

1.23

1.3

3.02

3.96

ug/l

1.49

1162

COPD, hospital admissions 1, only main diagnosis

228

0.60

1.23

1.1

1.6

3.53

4.80

ug/l

0.28

163

Viral hepatitis, IBD co-morbidity

433

0.69

1.23

1.3

2.86

3.98

ug/l

0.77

400

Other specified/unspecified soft tissue disorders

139

1.59

1.23

1.6

2.15

5.12

ug/l

0.92

123

Psoriatic arthropathies

350

0.66

1.22

1.1

1.3

2.90

3.86

ug/l

0.40

296

Deep bite

104

746

1.23

1.22

1.5

1.4

5.29

4.98

ug/l

0.09

694

Acute appendicitis

513

5230

0.92

1.22

1.4

1.3

4.30

3.41

ug/l

0.46

453

4696

Pulmonary heart disease

530

1.28

1.21

1.5

2.62

4.79

ug/l

1.20

420

Birth injury to peripheral nervous system

2.18

1.21

1.4

1.2

3.23

3.55

ug/l

—

Chronic viral hepatitis

360

0.66

1.20

1.4

1.3

2.24

3.31

ug/l

1.48

334

Personal history of allergy to drugs, medicaments and biological substances

1.86

1.20

1.2

2.22

2.81

ug/l

0.33

Transport accidents

439

4147

0.91

1.20

1.2

1.3

4.00

3.70

ug/l

0.16

411

3799

Injury, poisoning and certain other consequences of external causes

601

3272

0.92

1.20

1.4

1.3

4.16

3.85

ug/l

0.20

549

2986

Symptoms and signs involving the nervous and musculoskeletal systems

306

3420

0.89

1.20

1.4

3.87

3.95

ug/l

0.04

264

3025

Emotional disorders starting during childhood or adolescence

930

0.79

1.20

1.4

1.3

4.29

4.53

ug/l

0.19

890

Pulmonary embolism

531

1.28

1.20

1.5

2.62

4.79

ug/l

1.20

420

Hypo-osmolality and hyponatraemia

220

1.45

1.20

1.3

1.6

3.20

7.06

ug/l

0.79

162

Senile cataract

358

0.74

1.18

1.8

2.0

61.50

5.76

ug/l

0.73

177

Phakomatoses, not elsewhere classified

1.95

1.18

2.2

1.4

2.17

3.42

ug/l

0.87

Abrasion of teeth

202

1759

1.15

1.18

1.3

1.4

2.83

3.90

ug/l

1.86

169

1499

Other cataract

475

0.75

1.18

2.0

1.8

21.37

4.41

ug/l

0.43

315

Mental and behavioural disorders due to sedatives or hypnotics

370

0.67

1.18

1.4

2.80

3.31

ug/l

0.31

337

Umbilical hernia

1083

0.81

1.17

1.2

1.3

2.78

3.80

ug/l

1.19

971

Alcohol abuse, main dg

805

0.78

1.17

1.3

3.11

3.96

ug/l

1.05

752

Benign neoplasm: Skin of eyelid, including canthus

341

1.35

1.17

1.5

1.6

2.44

4.28

ug/l

1.09

270

IBD patients in KELA-register

156

1820

0.86

1.17

1.2

1.3

2.43

3.79

ug/l

4.56

146

1656

Major coronary heart disease event excluding revascularizations

303

0.70

1.16

2.2

2.1

2.30

8.15

ug/l

1.14

147

Urticaria and erythema

368

3327

1.11

1.16

1.3

2.93

3.80

ug/l

3.12

326

3020

Trigger finger

509

0.73

1.16

1.4

1.5

2.45

3.63

ug/l

0.92

414

L04AA Selective immunosuppressants

1157

0.82

1.15

1.5

1.4

3.27

3.91

ug/l

0.25

1004

Other reaction to severe stress, and adjustment disorders

487

4466

1.09

1.15

1.5

1.3

3.48

3.49

ug/l

0.00

443

4094

Effects of heat and light

2.53

1.15

1.2

5.68

3.91

ug/l

—

Graves disease, strict definition

102

841

1.22

1.15

1.3

2.38

4.02

ug/l

2.41

759

Reactive arthropathies

386

1.33

1.15

1.6

1.3

4.90

4.03

ug/l

0.16

342

Pain associated with micturition

562

1.27

1.14

1.3

1.4

3.16

3.94

ug/l

0.65

496

Nonsuppurative otitis media

355

3395

0.90

1.14

1.2

1.3

3.67

3.98

ug/l

0.80

340

3248

Juvenile osteochondrosis

301

1.37

1.13

1.2

1.4

3.47

3.36

ug/l

0.08

281

Biological medicines for asthma

113

0.44

1.13

1.0

1.5

3.94

2.93

ug/l

—

101

Benign neoplasm: Adrenal gland

103

1.65

1.12

1.4

1.6

1.64

6.60

ug/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

907

0.80

1.12

1.4

1.2

4.29

4.47

ug/l

0.13

874

Other symptoms and signs involving the urinary system

250

1.40

1.12

1.3

1.4

6.64

3.41

ug/l

0.42

217

Reactive arthropathies, FINNGEN

336

1.34

1.11

1.7

1.4

5.27

4.05

ug/l

0.21

301

Benign neoplasm of breast

663

1.24

1.11

1.6

1.4

2.82

4.06

ug/l

1.46

582

Primary gonarthrosis, bilateral

394

0.72

1.11

2.2

2.0

10.43

12.05

ug/l

0.06

162

Follicular cysts of skin and subcutaneous tissue

717

1.23

1.11

1.3

1.4

2.76

3.75

ug/l

1.20

627

Other special examinations and investigations of persons without complaint or reported diagnosis

604

2824

1.08

1.11

1.4

1.3

3.43

4.06

ug/l

0.67

538

2568

Post-traumatic stress disorder

134

1571

0.85

1.11

1.2

1.3

3.64

3.86

ug/l

0.22

120

1486

Inflammatory bowel disease, strict (require KELA)

156

1809

0.86

1.10

1.2

1.3

2.43

3.78

ug/l

4.51

146

1644

Abnormal blood-pressure reading, without diagnosis

201

1.45

1.10

1.9

1.5

3.19

4.70

ug/l

0.49

177

Benign neoplasm: Sigmoid colon

168

1.49

1.09

1.6

1.8

25.43

5.58

ug/l

0.44

110

Car occupant injured in other and unspecified transport accidents

160

1850

0.86

1.09

1.2

1.3

5.12

3.65

ug/l

0.36

155

1713

Other viral diseases, not elsewhere classified

291

2597

1.12

1.08

1.3

3.55

3.91

ug/l

0.61

260

2388

Complications of procedures, not elsewhere classified

608

4665

1.08

1.4

1.3

3.33

3.48

ug/l

0.14

508

4161

Asthma, hospital admission 2, infections

388

4167

0.91

1.08

1.3

3.76

4.06

ug/l

0.25

348

3730

Asthma-related infections

388

4167

0.91

1.08

1.3

3.76

4.06

ug/l

0.25

348

3730

Other symptoms and signs involving cognitive functions and awareness

1085

0.83

1.07

1.9

1.5

3.15

4.56

ug/l

0.86

892

Ankyloglossia

204

0.58

1.07

1.3

3.15

5.35

ug/l

1.14

192

Combinations of oral blood glucose lowering drugs

243

0.62

1.07

1.0

1.7

5.24

7.19

ug/l

—

157

Inflammatory disorders of breast

1066

0.82

1.06

1.4

1.3

3.23

4.01

ug/l

0.93

1005

Nontoxic multinodular goitre

479

1.28

1.06

1.2

1.7

2.28

4.87

ug/l

1.34

360

Focal epilepsy, mode (most common among epilepsy diagnosis)

881

0.80

1.06

1.1

1.4

2.84

4.39

ug/l

2.13

790

Other enthesopathy of foot (+metatarsalgia)

542

1.26

1.06

1.1

1.4

2.32

3.82

ug/l

1.83

473

Covid-19 confirmed case

238

2114

1.13

1.06

1.3

3.23

3.77

ug/l

0.73

214

1918

Oral lichen planus, including avohilmo , including avohilmo

145

1.52

1.06

1.1

1.6

2.76

4.98

ug/l

0.53

112

Injury of muscle and tendon at wrist and hand level

454

0.73

1.05

1.3

1.4

2.60

3.92

ug/l

1.15

399

Thyroiditis

454

1.28

1.05

1.5

1.4

4.10

3.79

ug/l

0.05

409

Chronic periodontitis, complicated

113

1327

0.84

1.04

1.5

2.68

4.80

ug/l

2.02

1048

Open wound of forearm

544

0.75

1.04

1.3

3.25

3.88

ug/l

0.37

506

Fracture of rib(s), sternum and thoracic spine

646

0.77

1.04

2.0

1.4

10.35

4.09

ug/l

0.42

554

Hydronephrosis

358

1.32

1.03

2.0

1.4

2.99

4.44

ug/l

0.91

316

Other and unspecified effects of external causes

242

2711

0.89

1.03

1.3

3.54

3.76

ug/l

0.17

223

2489

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

497

0.74

1.03

1.3

2.95

3.65

ug/l

0.45

452

Dermatitis due to substances taken internally

324

1.33

1.02

1.3

1.4

6.05

4.43

ug/l

0.27

299

Multiple delivery

898

0.81

1.02

1.9

1.3

4.48

2.62

ug/l

1.57

777

COPD related to multimorbidity

182

0.60

1.02

1.0

1.9

5.50

9.10

ug/l

—

107

Superficial injury of wrist and hand

174

1987

0.87

1.01

1.4

1.3

3.78

3.89

ug/l

0.07

167

1833

Bacterial pneumonia (organism specified)

148

1552

0.86

1.01

1.5

1.4

2.68

4.21

ug/l

2.83

129

1366

Recurrent aphthous stomatitis , including avohilmo

105

881

1.19

1.01

1.3

1.4

4.08

4.05

ug/l

0.01

804

Psoriatic arthropathies, ICD10

334

0.69

1.01

1.1

1.4

2.90

3.76

ug/l

0.34

279

138

1186

1.17

1.01

1.6

1.3

3.75

3.66

ug/l

0.03

122

1090

Heterophoria

709

1.22

1.00

1.2

1.3

4.63

4.18

ug/l

0.12

661

Varus deformity, not elsewhere classified

2.02

1.00

1.1

1.3

1.98

3.71

ug/l

—

Benign neoplasm of mouth and pharynx

299

1.34

1.00

1.2

1.5

2.04

4.10

ug/l

1.56

255

Erosion of teeth , including avohilmo

281

2532

1.11

1.00

1.4

1.3

3.39

3.75

ug/l

0.35

263

2322

Stroke, excluding SAH

535

0.79

0.99

2.2

1.7

5.72

5.29

ug/l

0.06

368

Crohn disease (strict definition, require KELA)

493

0.75

0.99

1.4

1.3

2.43

4.10

ug/l

2.04

456

Paroxysmal tachycardia

117

1150

0.85

0.98

1.5

1.3

8.08

4.29

ug/l

0.30

1014

Irritable bowel syndrome

258

2316

1.12

0.98

1.3

2.92

3.82

ug/l

2.13

238

2073

Transient ischemic attack

510

0.78

0.98

2.1

1.7

2.32

5.47

ug/l

1.59

341

Acidosis

2.18

0.98

1.8

1.5

1.94

2.88

ug/l

—

Arthropathic psoriasis

355

0.70

0.98

1.1

1.4

3.42

3.73

ug/l

0.10

299

Persons with potential health hazards related to communicable diseases

595

5499

1.07

0.98

1.3

3.40

3.58

ug/l

0.43

559

5117

Pyogenic granuloma

1.64

0.97

1.2

3.45

2.86

ug/l

0.44

Crohn disease (strict definition, require KELA, min 2 HDR)

492

0.75

0.97

1.4

1.3

2.43

4.10

ug/l

2.02

455

Seropositive rheumatoid arthritis, strict definition

504

0.75

0.97

1.1

1.5

3.81

3.84

ug/l

0.01

419

Other or unspecified ileus, impaction or obstruction

283

1.34

0.97

1.2

1.6

1.65

4.59

ug/l

1.83

218

Other systemic involvement of connective tissue

117

1371

0.85

0.97

1.2

1.4

2.54

4.11

ug/l

2.59

1182

Other disorders of pigmentation

132

1.52

0.97

1.3

1.4

12.51

3.08

ug/l

0.52

112

Carcinoma in situ of other and unspecified genital organs

1.75

0.97

1.3

4.48

2.59

ug/l

—

Other inflammation of eyelid

594

1.23

0.97

1.5

1.4

5.14

3.83

ug/l

0.32

525

Venous thromboembolism

170

1437

1.14

0.96

1.7

1.4

2.67

4.00

ug/l

1.77

126

1166

Haemangioma and lymphangioma, any site

389

1.29

0.96

1.4

2.62

4.25

ug/l

1.18

344

Asthma, excluding more controls

677

3775

0.93

0.96

1.3

2.92

3.65

ug/l

3.71

615

3427

Supernumerary teeth EXCLUDE clefts and syndromes

1.81

0.96

2.6

1.5

3.42

3.64

ug/l

—

L04AC Interleukin inhibitors

318

0.69

0.96

1.5

1.3

1.90

3.34

ug/l

1.62

288

Other/unspecified enthesopathies, not elsewhere classified

223

0.63

0.96

1.6

1.5

3.19

4.40

ug/l

—

188

Other diseases of hard tissues of teeth

347

1631

1.10

0.96

1.4

1.3

3.90

4.28

ug/l

0.20

307

1439

KRA_PSY_EATING, excluding more controls

239

2134

1.12

0.95

1.3

1.2

3.82

3.66

ug/l

0.14

231

2048

Bell's palsy

514

1.25

0.95

1.7

1.4

3.09

3.93

ug/l

0.60

460

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

524

0.76

0.95

1.3

2.30

4.03

ug/l

2.38

485

Benign neoplasm: Short bones of lower limb

1.78

0.95

3.4

1.2

15.75

3.46

ug/l

—

Benign neoplasm: Rectum, anus and anal canal

199

1.41

0.95

2.1

1.7

2.26

4.89

ug/l

0.87

137

Autoimmune hyperthyroidism

417

1.28

0.94

1.4

2.42

3.85

ug/l

1.38

376

Asthma, hospital admissions , main diagnosis only

650

6120

0.94

1.3

3.40

3.75

ug/l

0.62

584

5516

Sulfasalazine

150

1720

0.87

0.94

1.2

1.3

3.31

3.89

ug/l

0.64

130

1501

Other viral diseases

315

2857

1.10

0.94

1.3

3.53

3.99

ug/l

0.74

286

2646

Certain infectious and parasitic diseases

986

4671

1.06

0.94

1.4

1.3

3.70

3.83

ug/l

0.12

881

4246

Phlebitis and thrombophlebitis (not including DVT)

760

1.20

0.94

1.6

1.3

2.57

4.20

ug/l

1.33

641

Allergic urticaria

697

1.21

0.94

1.2

1.4

2.82

4.20

ug/l

2.08

641

Left ventricular outflow tract obstruction (LVOTO), broad definition

251

1.36

0.93

1.3

1.5

7.42

4.82

ug/l

0.30

217

Inflammatory disease of uterus

227

2033

1.12

0.93

1.3

3.05

3.57

ug/l

1.19

210

1868

Other diseases of blood and blood-forming organs

142

1.48

0.92

1.1

1.5

2.32

2.61

ug/l

0.19

118

Other disorders of kidney and ureter

226

1.37

0.92

1.3

1.5

3.53

4.37

ug/l

0.24

182

Myopia

165

1450

1.14

0.92

1.3

4.35

3.89

ug/l

0.27

153

1345

Trochanteric bursitis

419

0.74

0.91

1.1

1.7

2.51

4.90

ug/l

1.04

326

Leisure time condition

1071

0.84

0.91

2.1

1.3

6.24

3.89

ug/l

0.27

977

Sequelae of injuries, of poisoning and of other consequences of external causes

1071

0.84

0.91

1.4

1.3

2.88

4.02

ug/l

1.64

939

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

106

1244

0.85

0.91

1.3

1.4

3.13

3.94

ug/l

0.97

1101

Postpartum haemorrhage due to anatomy

316

2887

1.10

0.91

1.2

3.52

3.73

ug/l

0.35

293

2761

Myocardial infarction, strict

200

0.68

0.91

1.1

2.0

1.47

9.72

ug/l

—

102

Atopic dermatitis, strict definition

401

4256

0.92

0.91

1.4

1.3

5.01

3.73

ug/l

1.22

364

3962

Ischaemic Stroke, excluding all haemorrhages

463

0.79

0.90

2.4

1.7

4.15

5.68

ug/l

0.33

315

Convalescence

236

1.36

0.90

1.6

1.5

2.37

4.92

ug/l

1.25

206

Aortic valve malfunction, age under 60 years

185

1.41

0.89

1.2

1.5

4.27

5.13

ug/l

0.21

155

Episodal and paroxysmal disorders

1039

5565

0.95

0.89

1.3

3.62

3.79

ug/l

0.24

945

5073

Thyrotoxicosis

179

1585

1.13

0.88

1.2

1.4

2.45

3.79

ug/l

2.81

153

1387

Abnormalities of forces of labour

116

997

1.17

0.88

1.4

1.3

4.22

3.73

ug/l

0.17

105

858

Other psoriatic arthropathies

324

0.71

0.88

1.1

1.4

2.90

3.81

ug/l

0.36

271

Angina pectoris

294

0.75

0.88

1.3

2.1

0.98

8.69

ug/l

1.76

139

Asthma

679

3791

0.94

0.88

1.3

3.00

3.82

ug/l

2.72

616

3432

Peripheral artery disease

221

0.68

0.87

2.1

1.9

1.78

7.16

ug/l

—

151

Fall on same level involving ice and snow

299

3276

0.91

0.87

1.4

3.34

4.02

ug/l

1.20

260

2884

Anogenital herpesviral [herpes simplex] infection

208

1864

1.12

0.87

1.3

3.63

3.77

ug/l

0.11

193

1762

Purpura and other haemorrhagic conditions

612

1.21

0.86

1.6

1.3

3.86

3.99

ug/l

0.07

549

Ethmoidectomy

605

0.79

0.86

1.5

1.4

2.66

3.95

ug/l

1.37

538

Ankylosing spondylitis

380

0.73

0.86

1.1

1.4

4.09

3.85

ug/l

0.09

347

Other viral diseases

459

4232

1.08

0.86

1.3

3.52

3.77

ug/l

0.48

416

3913

Asthma (only as main-diagnosis), excluding more controls

619

3775

0.94

0.86

1.3

3.07

3.65

ug/l

2.12

557

3427

Malaise and fatigue

262

2325

0.91

0.86

1.5

1.3

3.36

3.80

ug/l

0.33

228

2068

Embedded and impacted teeth

595

4605

1.07

0.85

1.3

1.2

3.71

3.72

ug/l

0.02

572

4393

Other disorders of breast

127

1103

1.15

0.85

1.3

5.73

3.91

ug/l

0.23

109

977

Implicit viral Sepsis

732

1.19

0.85

1.4

4.46

4.08

ug/l

0.19

663

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

299

1.31

0.85

1.4

1.3

7.28

4.13

ug/l

0.52

277

Postdysenteric arthropathy

1.95

0.84

1.5

1.3

18.91

3.02

ug/l

—

Dental operations

300

1691

0.91

0.84

1.4

3.63

4.02

ug/l

0.24

259

1471

Myeloproliferative diseases (CML excluded)

104

1.54

0.84

1.1

1.8

2.45

6.26

ug/l

—

Other benign neoplasms of connective and other soft tissue

362

1.27

0.84

1.4

1.5

3.01

4.36

ug/l

0.81

312

Cardiomyopathy

196

1.38

0.83

1.6

2.23

5.14

ug/l

1.18

149

Follow-up care involving plastic surgery

154

1.43

0.83

1.4

1.5

1.63

4.74

ug/l

1.15

135

False labour

594

3473

1.07

0.83

1.2

1.3

4.37

3.32

ug/l

1.15

561

3168

Sleep disorders (combined)

1053

5260

1.05

0.83

1.3

3.48

3.68

ug/l

0.33

949

4756

Benign neoplasm: Stomach

129

1.48

0.83

1.2

1.9

3.53

5.62

ug/l

0.36

Assault

1037

0.85

0.82

1.3

3.26

4.04

ug/l

0.75

972

Viral Sepsis

735

1.19

0.82

1.4

4.46

4.07

ug/l

0.19

665

Acute pharyngitis

174

1935

0.89

0.82

1.3

3.49

4.13

ug/l

0.77

158

1844

Dermatitis

366

3945

0.92

0.81

1.3

3.09

3.78

ug/l

0.93

324

3475

Demyelinating diseases of the central nervous system

774

0.82

0.81

1.2

1.3

2.58

3.71

ug/l

1.54

709

Fentanyl

1.55

0.80

1.1

1.8

1.09

3.96

ug/l

—

Mental and behavioural disorders due to tobacco

352

0.74

0.80

1.2

1.4

16.03

4.01

ug/l

0.40

313

Systemic connective tissue disorders

153

1727

0.88

0.79

1.3

1.4

2.34

3.94

ug/l

3.85

125

1478

Other specified and unspecified strabismus

1.68

0.79

1.3

1.2

13.21

3.21

ug/l

0.50

Arthropathy in ulcerative colitis

1.68

0.79

1.3

1.2

2.35

2.88

ug/l

0.31

Focal epilepsy, strict definition

881

0.84

0.79

1.1

1.4

2.84

4.78

ug/l

2.40

790

FESS (DNB20)

597

0.80

0.79

1.5

1.4

2.66

3.98

ug/l

1.41

531

Viral warts

785

1.18

0.79

1.3

6.73

3.91

ug/l

0.38

729

Malignant neoplasm of pancreas

0.00

0.79

0.0

1.1

—

2.82

—

Missing teeth due to accident, extraction or parodontitis

140

1496

0.88

0.78

1.6

1.5

3.58

4.66

ug/l

0.40

104

1191

External causes of morbidity and mortality

713

3782

0.94

0.78

1.4

1.3

4.08

3.75

ug/l

0.24

633

3459

Metatarsalgia

492

1.22

0.78

1.1

1.4

2.39

3.72

ug/l

1.33

433

Fracture of shoulder and upper arm

126

1436

0.88

0.78

1.3

1.4

3.59

4.74

ug/l

1.29

108

1257

Obesity due to excess calories

428

4592

0.93

0.78

1.3

3.71

3.48

ug/l

0.28

389

4166

All chronic kidney diseases

196

1781

0.90

0.77

1.7

1.4

5.21

4.02

ug/l

0.52

162

1568

Lesion of sciatic nerve

0.00

0.77

0.0

1.3

—

2.67

—

Myeloproliferative diseases

123

1.47

0.77

1.1

1.7

2.66

5.71

ug/l

0.67

Pregnancy hypertension

630

5325

1.06

0.77

1.3

3.73

3.42

ug/l

0.30

562

4824

Presence of cardiac and vascular implants and grafts

235

0.73

0.77

1.1

1.7

2.92

7.27

ug/l

0.89

161

Malignant neoplasm of thyroid gland

217

1.34

0.77

1.4

1.2

1.35

2.63

ug/l

3.91

191

Other osteochondrodysplasias

1.72

0.76

1.4

1.2

1.40

3.46

ug/l

—

Certain infectious and parasitic diseases

683

3228

1.06

0.76

1.4

1.3

3.92

3.96

ug/l

0.03

603

2917

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

714

0.82

0.76

1.2

1.4

11.19

3.67

ug/l

0.52

643

Stomatitis and related lesions

152

1349

1.13

0.76

1.3

3.72

4.06

ug/l

0.21

131

1226

Symptoms and signs concerning food and fluid intake

484

1.22

0.76

1.2

1.4

4.48

4.69

ug/l

0.04

439

Disorders of mineral metabolism

226

1.33

0.76

1.6

1.4

2.52

4.23

ug/l

0.63

193

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.76

0.0

1.7

—

1.85

—

Contact with and exposure to communicable diseases

542

5075

1.07

0.75

1.2

1.3

3.51

3.61

ug/l

0.19

509

4746

Gastroduodenal ulcer

278

1.29

0.75

1.3

1.7

2.50

5.91

ug/l

0.98

208

Other/unspecified reactive arthropathies

306

1.28

0.75

1.8

1.4

5.45

3.35

ug/l

0.34

277

Papulosquamous disorders

134

1517

0.88

0.74

1.3

1.4

3.12

4.05

ug/l

1.05

106

1291

Desensitization to allergens

680

1.18

0.74

1.2

1.3

3.26

3.72

ug/l

0.35

642

Spondylopathies (FG)

1014

0.86

0.74

1.4

1.3

4.82

3.81

ug/l

0.29

918

Contact with hypodermic needle

1.58

0.73

1.5

1.3

7.34

3.12

ug/l

0.43

Other disorders of amniotic fluid and membranes

312

2814

1.09

0.73

1.2

1.3

3.01

3.09

ug/l

0.18

289

2605

Psoriatic and enteropathic arthropathies

469

0.79

0.73

1.2

1.4

2.74

3.64

ug/l

0.64

404

Gestational [pregnancy-induced] hypertension

402

4296

0.93

0.72

1.3

4.11

3.12

ug/l

0.87

366

3936

Smoking dependency

345

0.75

0.72

1.2

1.4

16.03

3.98

ug/l

0.40

306

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

721

0.83

0.72

1.5

2.16

4.27

ug/l

1.68

551

Glucagon-like peptide-1 (GLP-1) analogues

721

0.83

0.72

1.5

2.16

4.27

ug/l

1.68

551

Other diseases of pleura

531

1.19

0.72

1.4

1.6

3.29

5.17

ug/l

0.70

414

Other hearing loss

415

1.23

0.72

1.5

1.6

2.46

5.12

ug/l

1.25

324

Fracture of skull and facial bones

113

988

1.15

0.72

2.0

1.3

4.01

3.74

ug/l

0.09

103

891

Social phobias

109

1245

0.87

0.72

1.3

3.32

4.01

ug/l

0.95

1177

Congenital malformations of the circulatory system

107

904

1.15

0.72

1.4

6.27

4.76

ug/l

0.34

833

Pain (limb, back, neck, head abdominally)

656

3105

1.06

0.72

1.4

1.3

4.40

4.03

ug/l

0.22

591

2837

Implicit viral Sepsis

130

1148

1.13

0.71

1.4

4.11

4.53

ug/l

0.24

115

1029

Atrial fibrillation and flutter

362

0.81

0.71

1.7

1.5

2.32

4.77

ug/l

1.49

249

In situ neoplasms

246

2251

1.09

0.71

1.2

1.4

5.99

3.40

ug/l

0.64

215

2013

Excluding asthma or asthma-COPD overlap

722

3813

0.95

0.71

1.4

1.3

3.89

3.81

ug/l

0.05

640

3451

Other pulmonary diagnosis

722

3813

0.95

0.71

1.4

1.3

3.41

3.81

ug/l

0.63

642

3451

Complications of surgical and medical care, not elsewhere classified

707

5100

0.95

0.71

1.5

1.3

3.43

3.49

ug/l

0.06

586

4584

Other antidepressants

824

4434

0.95

0.71

1.3

3.45

3.81

ug/l

0.60

725

4020

Neurological diseases

956

5027

0.95

0.70

1.3

3.84

3.80

ug/l

0.05

875

4620

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

658

5423

1.06

0.70

1.3

4.37

3.36

ug/l

0.74

586

4897

Other congenital malformations of tongue, mouth and pharynx

141

0.63

0.70

1.4

4.06

5.15

ug/l

—

132

Inflammatory bowel disease

202

2224

0.91

0.70

1.2

1.3

2.51

3.72

ug/l

4.49

187

2012

Intrahepatic Cholestasis of Pregnancy (ICP)

101

1156

0.87

0.70

1.3

3.02

3.78

ug/l

0.99

1074

Atopic dermatitis, strict definition with reimbursement

425

4379

0.94

0.69

1.4

1.3

4.79

3.64

ug/l

1.14

385

4063

Infections, IBD-co-morbidities

113

706

1.14

0.69

1.4

3.62

5.38

ug/l

0.61

620

Injuries to the ankle and foot

726

6134

1.05

0.69

1.3

3.23

3.77

ug/l

2.05

664

5575

Other and unspecified disorders of binocular movement

1.69

0.69

1.1

1.3

2.33

3.89

ug/l

—

Superficial injury of forearm

835

0.85

0.69

1.3

2.93

3.97

ug/l

1.73

786

Other and unspecified visual disturbances

482

1.21

0.69

1.7

1.4

2.65

4.30

ug/l

1.85

431

Coxarthrosis, primary, with hip surgery

278

0.74

0.69

2.6

2.3

4.36

10.08

ug/l

—

107

Nonorganic sleeping disorders

223

2037

1.10

0.68

1.3

3.98

3.73

ug/l

0.16

200

1870

Myocardial infarction

233

0.75

0.68

1.6

2.1

1.33

9.76

ug/l

1.52

115

Disorders of vestibular function (Vertigo)

174

1544

1.11

0.67

1.6

1.4

3.02

4.14

ug/l

1.45

137

1257

Other symptoms and signs involving general sensations and perceptions

168

0.65

0.67

1.4

3.90

3.15

ug/l

0.33

150

Granuloma annulare

0.55

0.67

1.0

1.3

4.07

2.68

ug/l

—

Lesion of radial nerve

0.55

0.67

1.0

1.5

3.49

2.32

ug/l

—

341

3631

0.93

0.67

1.3

3.93

3.97

ug/l

0.02

305

3283

Benign neoplasm of colon, rectum, anus and anal canal

109

830

1.14

0.66

1.5

1.6

8.17

5.03

ug/l

0.25

578

Peritonsillar abscess

202

2215

0.91

0.66

1.2

1.3

3.23

3.55

ug/l

0.51

184

2040

Hypothyroidism due to medicaments and other exogenous substances

1.79

0.66

2.4

1.4

1.43

2.82

ug/l

—

Spondyloarthritis

1035

0.87

0.66

1.4

1.3

4.77

3.89

ug/l

0.25

937

Mental and behavioural disorders associated with the puerperium

154

1.38

0.66

1.3

1.4

4.30

2.95

ug/l

0.38

139

Lichen sclerosus et atrophicus

303

1.26

0.66

1.2

1.6

3.36

4.03

ug/l

0.26

242

D07AA Corticosteroids, weak (group I)

147

1635

0.90

0.66

1.3

3.91

4.13

ug/l

0.11

138

1521

Intracranial injury

376

3802

0.93

0.65

1.3

4.19

3.97

ug/l

0.09

339

3472

Other specified and unspecified retinal disorders

1.54

0.65

1.7

1.4

8.62

2.49

ug/l

0.48

Other predominantly sexually transmitted diseases, not elsewhere classified

270

2495

1.08

0.65

1.2

1.3

3.12

3.44

ug/l

0.64

253

2321

Disorders of thyroid, IBD co-morbidities

224

1718

0.91

0.65

1.3

3.01

3.99

ug/l

0.73

199

1590

Other obstructed labour

736

1.16

0.65

1.2

1.3

7.88

3.98

ug/l

0.40

651

Abnormal involuntary movements

578

1.18

0.64

1.4

3.40

4.14

ug/l

0.53

517

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

439

2065

1.07

0.64

1.4

1.3

4.00

4.09

ug/l

0.05

403

1920

Dysphagia

708

1.16

0.64

1.3

1.4

5.71

3.79

ug/l

0.27

600

COPD differential diagnosis

724

3809

0.95

0.64

1.4

1.3

3.40

3.90

ug/l

0.81

642

3443

Impacted teeth

449

3761

1.06

0.64

1.3

1.2

3.86

3.84

ug/l

0.02

432

3602

Anaemia in chronic diseases classified elsewhere

1.73

0.64

4.0

1.4

1.86

3.63

ug/l

—

Abnormal results of function studies

368

1.23

0.64

1.3

1.4

3.60

4.27

ug/l

0.34

330

Pulmonary heart disease, diseases of pulmonary circulation

597

1.17

0.63

1.5

2.71

4.75

ug/l

1.27

475

Acute bronchitis

210

2248

0.91

0.63

1.4

1.3

4.00

3.94

ug/l

0.03

187

2020

Sequelae with surgical and medical care as external cause

653

1.17

0.63

1.4

4.31

4.12

ug/l

0.04

566

Other infectious diseases

323

1.24

0.63

1.8

1.4

2.47

3.37

ug/l

0.93

289

Asthma (only as main-diagnosis)

622

3791

0.95

0.63

1.3

3.15

3.82

ug/l

1.73

558

3432

ILD differential diagnosis

724

3806

0.95

0.63

1.4

1.3

3.41

3.90

ug/l

0.80

641

3441

Nephropathy related operations

234

1.28

0.62

2.2

1.5

2.93

4.34

ug/l

0.48

201

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

103

1166

0.88

0.62

1.3

3.02

3.77

ug/l

0.98

1076

Dermatographic urticaria

590

1.17

0.62

1.3

2.83

3.80

ug/l

0.93

547

Congenital dislocation of hip, unilateral

1.62

0.62

1.8

1.5

3.16

3.06

ug/l

—

Nontoxic goitre/thyroid nodule

106

936

1.13

0.61

1.4

1.5

2.46

4.46

ug/l

1.88

730

Whooping cough

138

0.65

0.61

1.2

2.42

3.10

ug/l

—

128

Early onset COPD, excluding more controls

290

0.76

0.61

1.2

1.6

2.97

6.43

ug/l

0.90

215

Symptoms and signs involving the circulatory and respiratory systems

1044

5440

0.96

0.61

1.3

3.25

3.79

ug/l

1.60

943

4964

Asthma (mode)

677

3806

0.95

0.61

1.3

3.00

3.90

ug/l

2.92

613

3441

Retinal breaks without detachment

244

1.27

0.61

1.5

1.7

2.48

5.08

ug/l

1.01

167

Scoliosis

113

1004

1.13

0.61

1.4

1.3

3.35

4.06

ug/l

1.03

105

953

All influenza (not pneumonia)

703

1.15

0.60

1.4

3.39

4.94

ug/l

1.39

643

Diseases of the eye and adnexa

994

4782

1.04

0.60

1.3

3.57

3.61

ug/l

0.05

902

4400

Secondary parkinsonism

0.00

0.60

0.0

1.6

—

3.18

—

Abnormalities of heart beat

224

2382

0.92

0.59

1.3

1.4

2.97

4.00

ug/l

2.30

196

2126

Unstable angina pectoris

129

0.67

0.59

1.1

2.2

0.46

14.24

ug/l

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

0.59

0.0

1.5

—

3.29

—

Other mycoses, not elsewhere classified/unspecified

1.54

0.59

1.4

1.3

3.06

3.24

ug/l

0.07

Fracture at wrist and hand level

191

2081

0.91

0.59

1.4

1.3

4.26

3.89

ug/l

0.18

174

1886

Hyperkinetic disorders (excl. ADHD)

172

0.69

0.59

1.2

1.4

12.37

5.16

ug/l

0.37

160

Use of pramipexole

445

1.19

0.59

1.3

1.5

2.18

5.19

ug/l

1.61

345

Carbimazole or st.post thyroidectomy, condition for graves disease

154

1395

1.11

0.59

1.3

1.4

2.27

3.93

ug/l

3.26

133

1218

Other viral hepatitis

421

0.81

0.59

1.3

3.00

3.21

ug/l

0.14

391

Fracture of foot, except ankle

173

1895

0.91

0.58

1.2

1.3

3.00

3.92

ug/l

2.28

159

1725

Deviated nasal septum

958

0.88

0.58

1.1

1.3

3.16

4.30

ug/l

0.90

814

Certain conditions originating in the perinatal period

136

1087

1.11

0.58

1.4

1.3

4.99

4.70

ug/l

0.12

129

1037

Other neurotic disorders

114

0.61

0.58

1.3

1.4

2.23

3.50

ug/l

—

Benign neoplasm: Lip

1.72

0.57

1.2

1.3

2.34

3.60

ug/l

—

Other and unspecified urticaria

189

1733

1.09

0.57

1.3

2.97

3.83

ug/l

1.72

173

1566

Deforming dorsopathies

189

1733

1.09

0.57

1.4

3.24

4.06

ug/l

1.35

160

1543

Excessive vomiting in pregnancy

137

1238

1.11

0.57

1.2

1.3

3.46

3.45

ug/l

0.01

127

1144

Acute appendicitis, no complications

442

4649

0.95

0.56

1.4

1.3

3.47

3.44

ug/l

0.02

393

4184

Other disorders of conjunctiva

283

1.24

0.56

1.3

1.6

2.30

4.91

ug/l

1.51

226

Migraine with aura

353

3753

0.94

0.56

1.2

1.3

3.32

3.54

ug/l

0.44

329

3451

Other osteochondrodysplasias

1.55

0.56

1.4

1.2

1.40

3.25

ug/l

—

Other keratitis

775

1.14

0.55

1.3

2.77

4.11

ug/l

1.58

716

Sequelae of external causes of morbidity and mortality

105

935

1.12

0.55

1.3

1.4

3.95

4.20

ug/l

0.07

816

Undetermined asthma

709

0.86

0.55

1.4

1.3

2.49

4.01

ug/l

2.64

630

Use of peginterferon beta-1a

1.51

0.55

1.1

1.2

2.99

2.84

ug/l

—

Cyst of Bartholin Gland

330

1.22

0.55

1.4

1.3

6.14

3.43

ug/l

0.33

300

Speech and linguistic disorders

120

1035

1.12

0.55

1.4

1.3

4.18

4.72

ug/l

0.27

114

989

Oter anti-inflammatory and antirheumatic agents, non-steroids

274

0.83

0.55

1.7

1.4

3.85

5.26

ug/l

0.19

222

Phobic anxiety disorders

183

1987

0.92

0.54

1.3

3.28

3.90

ug/l

1.33

167

1878

Other gastritis (incl. Duodenitis)

546

0.84

0.53

1.4

1.5

4.88

4.54

ug/l

0.04

455

Single spontaneous delivery

416

2331

0.94

0.53

1.2

1.3

5.00

3.24

ug/l

2.28

392

2080

Heartburn

578

0.85

0.53

1.2

1.3

3.12

3.43

ug/l

0.31

525

Diseases of the respiratory system

621

3259

0.95

0.53

1.3

3.51

3.98

ug/l

0.64

556

2945

Basal cell carcinoma

209

1.23

0.53

1.5

1.1

3.27

2.38

ug/l

0.39

136

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.44

0.52

1.2

1.3

3.67

3.16

ug/l

—

Undetermined asthma, excluding more controls

705

0.86

0.52

1.4

2.49

4.01

ug/l

2.64

630

Tooth eruption problems

308

2821

1.07

0.52

1.3

3.95

4.03

ug/l

0.09

298

2702

Hepatic failure, not elsewhere classified

1.43

0.52

1.1

1.4

5.66

2.57

ug/l

—

Suppurative and unspecified otitis media

512

4761

0.95

0.52

1.3

4.53

3.55

ug/l

0.84

473

4470

Obesity, other/unspecified

351

3309

1.06

0.52

1.3

3.64

3.55

ug/l

0.08

322

2977

Provisional assignment of new diseases of uncertain etiology

475

4508

1.05

0.52

1.3

3.31

3.58

ug/l

0.57

430

4115

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

275

2854

0.94

0.51

1.2

1.3

3.28

3.90

ug/l

0.61

238

2498

Background retinopathy and retinal vascular changes

1.50

0.51

1.7

1.3

2.07

2.29

ug/l

—

Fitting and adjustment of other devices

559

0.86

0.51

1.6

2.18

5.47

ug/l

2.55

432

Other spirochaetal diseases

133

1207

1.10

0.51

1.7

1.4

3.76

3.91

ug/l

0.09

113

1021

Acute suppurative otitis media

393

3872

0.95

0.51

1.3

4.62

3.65

ug/l

0.58

363

3664

Codes for special purposes

475

4511

1.05

0.51

1.3

3.31

3.58

ug/l

0.57

430

4118

Other spirochaetal diseases

130

1179

1.10

0.51

1.7

1.4

3.65

3.91

ug/l

0.18

110

997

Care involving use of rehabilitation procedures

318

3107

0.94

0.51

1.6

1.4

3.39

4.12

ug/l

0.60

267

2683

Other disorders of eyelid

698

1.13

0.50

1.1

1.7

1.56

4.70

ug/l

2.97

492

Infections with a predominantly sexual mode of transmission

475

4516

1.05

0.50

1.2

1.3

3.02

3.34

ug/l

1.10

443

4184

Presence of other devices

497

0.84

0.50

1.5

1.4

3.38

4.99

ug/l

0.73

426

Explicit bacterial Sepsis

352

1.19

0.50

1.9

1.3

2.94

4.59

ug/l

1.15

321

Non-rheumatic valve diseases

684

0.89

0.50

1.3

1.6

2.80

5.30

ug/l

2.12

525

Female pelvic inflammatory disorders in diseases classified elsewhere

1.48

0.49

1.2

1.3

3.26

2.91

ug/l

0.16

Early onset COPD

280

0.79

0.49

1.2

1.6

2.97

4.32

ug/l

0.42

207

Non-ischemic cardiomyopathy

202

1.24

0.49

1.5

2.0

41.28

8.02

ug/l

0.37

134

Spirochaetal infections, other/unspecified

129

1172

1.10

0.49

1.7

1.4

3.60

3.92

ug/l

0.22

109

992

Burn and corrosion of head and neck

1.43

0.49

1.0

1.2

3.34

3.31

ug/l

0.01

Any reimbursement code in KELA

907

4383

1.04

0.49

1.4

1.2

3.46

3.63

ug/l

0.27

810

4164

Etanercept

400

0.82

0.49

1.1

1.3

2.67

3.89

ug/l

0.76

363

Superficial injury of head

114

1260

0.90

0.49

1.2

1.3

3.25

3.93

ug/l

0.87

102

1138

Viral hepatitis

443

0.83

0.49

1.3

2.93

3.20

ug/l

0.20

412

Dipeptidyl peptidase 4 (DPP-4) inhibitors

485

0.86

0.49

1.6

1.8

2.47

5.91

ug/l

1.44

299

Methotrexate

626

0.86

0.49

1.7

1.4

4.69

3.97

ug/l

0.12

531

Lesion of ulnar nerve

427

1.17

0.49

1.3

1.4

3.05

4.00

ug/l

0.58

363

Valvular heart disease excluding rheumatic fever

706

0.89

0.48

1.3

1.6

2.74

5.48

ug/l

2.54

547

Nonorganic sleeping disorders, excluding more controls

223

2078

1.07

0.48

1.3

1.2

3.98

3.53

ug/l

0.33

200

1928

Lichen simplex chronicus and prurigo

155

0.71

0.48

2.0

1.5

1.27

4.93

ug/l

—

132

Other specified disorders of external ear

1.52

0.48

1.7

1.3

2.26

3.00

ug/l

—

Lyme disease

127

1155

1.10

0.48

1.7

1.4

3.61

3.92

ug/l

0.21

107

975

Prolonged pregnancy

373

3093

1.06

0.48

1.2

1.3

3.75

3.17

ug/l

1.92

352

2877

Lateral epicondylitis

442

0.84

0.48

1.1

1.5

2.48

3.57

ug/l

0.65

351

Lifestyle-related condition

1.50

0.47

1.7

1.3

1.84

2.95

ug/l

—

Aortic aneurysm

1.42

0.47

2.2

1.7

3.09

6.09

ug/l

—

Vitamin B12 deficiency anaemia

128

1.33

0.47

1.3

1.6

2.63

5.77

ug/l

0.73

Other malignant neoplasms of skin (=non-melanoma skin cancer)

223

1.20

0.47

1.5

1.1

3.24

2.42

ug/l

0.39

147

Renal failure

533

0.86

0.47

1.8

1.6

3.18

5.16

ug/l

0.97

421

Abnormal findings on diagnostic imaging of lung

626

1.13

0.47

1.6

2.08

4.58

ug/l

1.54

450

Retained placenta and membranes, without haemorrhage

111

1005

1.11

0.47

1.3

2.70

3.73

ug/l

1.33

100

878

Basal cell carcinoma, including avohilmo

237

1.19

0.46

1.4

1.1

2.84

2.36

ug/l

0.23

157

Impingement syndrome of shoulder

365

0.82

0.46

1.4

1.8

2.49

8.48

ug/l

1.30

239

Somatoform disorder

134

1225

1.10

0.46

1.4

1.3

4.65

3.86

ug/l

0.23

111

1096

Other acute lower respiratory infections

321

3234

0.95

0.45

1.4

1.3

3.97

3.98

ug/l

0.01

294

2937

Other overlap syndromes

0.59

0.45

1.4

1.3

3.73

3.00

ug/l

—

Disturbances of skin sensation

230

2457

0.94

0.45

1.3

2.90

3.50

ug/l

1.57

205

2226

Disorders of optic nerve and visual pathways

684

1.13

0.45

1.4

2.33

3.94

ug/l

2.55

631

Diagnoses used for exclusion with ILD

505

1.15

0.45

2.1

1.5

3.10

4.00

ug/l

0.46

411

Impacted cerumen

209

0.76

0.45

1.3

1.5

1.90

3.19

ug/l

1.83

178

Otitis media, unspecified

142

1202

1.09

0.44

1.3

4.02

4.57

ug/l

0.61

132

1146

Congenital malformations and deformations of the musculoskeletal system

103

928

1.11

0.44

1.5

1.3

4.05

4.27

ug/l

0.08

874

Other diseases of the digestive system

714

1.12

0.44

1.3

1.4

3.16

4.40

ug/l

1.46

624

Other and unspecified nonscarring hair loss

1.43

0.44

1.2

3.14

3.16

ug/l

0.01

Congenital malformations and deformations of the musculoskeletal system

124

1128

1.10

0.43

1.4

1.3

3.77

4.75

ug/l

0.51

114

1052

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

433

4512

0.95

0.43

1.3

3.06

3.69

ug/l

3.29

396

4163

Ulcerative colitis

152

1645

0.92

0.43

1.2

1.3

2.46

3.85

ug/l

4.00

140

1483

Melanocytic naevi of lower limb, including hip

266

1.21

0.43

1.3

2.70

2.98

ug/l

0.17

243

Tinnitus

791

1.11

0.43

1.3

1.4

2.65

4.70

ug/l

1.72

663

Contusion of toe(s) without damage to nail

221

1.23

0.42

1.3

3.26

3.36

ug/l

0.05

205

Congenital varicose veins

1.58

0.42

1.4

1.2

2.46

3.00

ug/l

—

Other infectious diseases

239

1.22

0.42

2.0

1.5

2.17

3.34

ug/l

0.89

212

Diseases of salivary glands

211

1975

1.07

0.42

1.4

1.3

2.96

3.86

ug/l

1.67

179

1751

Acne

170

1824

0.93

0.42

1.3

3.45

3.92

ug/l

0.74

162

1744

Mouth breathing

118

1287

0.92

0.42

1.1

1.4

3.52

4.59

ug/l

0.78

1093

Retinal detachments and breaks

509

1.14

0.42

2.0

1.6

13.92

4.97

ug/l

0.37

369

Enthesopathies of lower limb, excluding foot

1090

0.91

0.42

1.2

1.4

2.47

3.98

ug/l

2.17

937

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

792

5331

0.97

0.42

1.5

1.3

3.98

3.68

ug/l

0.13

675

4810

5-aminosalicylic acid

147

1589

0.92

0.41

1.2

1.3

2.57

3.81

ug/l

3.20

136

1435

Benign neoplasm: Rectum

167

1.26

0.41

2.2

1.8

2.07

5.50

ug/l

0.95

110

Mixed connective tissue disease

294

0.81

0.41

1.2

1.4

3.10

3.86

ug/l

0.29

258

Other specified/unspecified disorders of ear

0.00

0.41

0.0

1.1

—

4.99

—

Hyperlipidaemia, other/unspecified

321

0.83

0.41

1.8

1.9

2.12

6.94

ug/l

1.37

195

Rosacea

642

1.12

0.41

1.2

1.4

2.43

3.85

ug/l

1.96

570

Trichomoniasis

0.00

0.41

0.0

1.4

—

2.74

—

Paracetamol or NSAID medication

205

964

1.07

0.41

1.3

3.47

4.20

ug/l

1.42

193

912

Dronedarone medication

0.00

0.41

0.0

1.8

—

4.44

—

Dialysis, with operation codes

240

1.21

0.41

2.0

1.5

2.99

4.34

ug/l

0.44

203

Mental and behavioural disorders of puerperium, not classified elsewhere

168

1.26

0.41

1.3

1.4

4.30

2.80

ug/l

0.43

153

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

4.18

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

249

0.83

0.41

2.1

1.6

2.58

4.57

ug/l

0.65

170

Asthma, hospital admissions 3, pneumonia

136

1470

0.92

0.40

1.3

1.4

3.59

4.48

ug/l

0.44

119

1280

Asthma-related pneumonia or sepsis

136

1470

0.92

0.40

1.3

1.4

3.59

4.48

ug/l

0.44

119

1280

Obesity and other hyperalimentation

628

5833

1.04

0.40

1.3

3.61

3.58

ug/l

0.03

571

5274

Viral conjunctivitis

141

1.28

0.40

1.3

1.4

3.94

2.83

ug/l

0.34

126

Opioids

1074

5420

1.03

0.40

1.4

1.3

3.60

3.62

ug/l

0.02

975

4960

Cerebral aneurysm, nonruptured

177

1.24

0.40

1.3

1.6

2.43

4.70

ug/l

0.72

135

Other diseases of upper respiratory tract

882

4742

0.97

0.40

1.4

1.3

3.65

3.85

ug/l

0.28

807

4270

Dementia, including avohilmo

187

0.81

0.40

1.9

2.1

4.44

9.15

ug/l

0.56

103

Accessory breast

1.43

0.40

1.1

1.2

4.86

3.15

ug/l

—

Acute and transient psychotic disorders

603

0.88

0.40

1.3

1.4

2.88

4.11

ug/l

0.90

549

Rash and other nonspecific skin eruption

446

1.15

0.39

1.6

1.4

4.92

4.05

ug/l

0.22

396

Amoebiasis

1.44

0.39

1.6

1.4

4.95

2.67

ug/l

—

Other and unspecified vascular occlusions

1.31

0.39

4.3

1.6

3.87

2.23

ug/l

—

Presbyopia

1.34

0.39

1.8

2.86

7.50

ug/l

—

Benign neoplasm: Anus and anal canal

1.43

0.39

1.8

1.3

3.09

3.40

ug/l

—

Chalazion

655

0.88

0.39

1.3

2.62

4.26

ug/l

1.60

598

Cerebral cysts

428

1.15

0.39

1.6

1.3

2.73

3.73

ug/l

1.06

397

Radial styloid tenosynovitis [de Quervain]

428

1.15

0.39

1.4

3.55

4.08

ug/l

0.23

393

Other and unspecified disorders of vitreous body

533

1.13

0.39

1.3

1.9

2.11

8.04

ug/l

1.75

305

Hypothyroidism, drug reimbursement

133

1016

0.92

0.39

1.2

2.36

3.37

ug/l

2.07

111

954

Cellulitis

1053

0.91

0.39

1.2

1.4

3.02

4.39

ug/l

1.77

945

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

112

1012

1.09

0.38

1.3

4.53

3.84

ug/l

0.28

957

Obesity

626

5832

1.04

0.38

1.3

3.61

3.58

ug/l

0.04

569

5273

Palatinal maxillary canine

113

0.70

0.38

1.0

1.5

2.30

3.83

ug/l

—

105

Fall on and from stairs and steps

117

1270

0.92

0.38

1.4

1.3

3.22

4.02

ug/l

0.96

101

1125

Pre-eclampsia or poor fetal growth

530

5088

1.04

0.38

1.3

3.24

3.34

ug/l

0.21

473

4670

Lichen planus

225

0.80

0.37

1.1

1.6

2.24

4.56

ug/l

—

172

Degeneration of macula and posterior pole

266

0.84

0.37

2.1

7.28

7.69

ug/l

0.04

141

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

117

1269

0.92

0.37

1.2

1.3

2.49

3.92

ug/l

3.08

107

1160

Iridocyclitis in diseases classified elsewhere

1.31

0.37

1.3

2.16

2.97

ug/l

—

Psoriasis vulgaris

695

1.11

0.37

1.2

1.4

3.16

3.78

ug/l

0.50

607

Other infestations

1.35

0.37

2.0

1.3

2.08

2.82

ug/l

—

Other and unspecified rosacea

383

1.15

0.37

1.2

1.4

2.28

3.99

ug/l

1.39

334

Unspecified privation

496

1.13

0.37

1.6

1.3

4.23

3.86

ug/l

0.10

449

Oedema, not elsewhere classified

137

1254

1.08

0.37

1.3

2.85

3.83

ug/l

1.38

120

1070

Colitis, primary sclerosing

1.29

0.37

1.3

2.45

3.08

ug/l

—

Benign neoplasm of urinary organs

1.39

0.36

2.1

1.9

1.02

4.88

ug/l

—

Acute pancreatitis

418

0.86

0.36

1.5

2.25

4.09

ug/l

1.52

349

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

171

1.24

0.36

1.3

1.2

4.30

3.52

ug/l

0.19

157

Poor fetal growth

297

2830

1.05

0.36

1.2

1.3

3.03

3.42

ug/l

1.04

273

2665

Fracture of forearm

335

3212

0.95

0.36

1.3

1.4

3.40

4.35

ug/l

2.00

300

2835

Injury of muscle and tendon at shoulder and upper arm level

439

0.87

0.36

1.1

1.6

2.14

5.46

ug/l

1.60

322

DVT of lower extremities and pulmonary embolism

101

922

1.09

0.36

1.4

1.5

2.38

4.24

ug/l

2.01

731

Chronic laryngitis and laryngotracheitis

431

1.14

0.36

1.6

1.4

1.73

3.94

ug/l

2.36

348

Symptoms and signs involving the skin and subcutaneous tissue

518

4885

1.04

0.36

1.4

1.3

2.93

3.72

ug/l

2.38

450

4343

Crowding of teeth, including avohilmo

134

1192

0.93

0.36

1.3

3.84

4.57

ug/l

1.02

121

1139

Ulcerative colitis (strict definition, all Crohn cases excluded)

995

0.91

0.35

1.2

1.3

2.61

3.97

ug/l

2.05

915

Asthma-related pneumonia

136

1459

0.93

0.35

1.3

1.4

3.59

4.48

ug/l

0.44

119

1271

Injury of eye and orbit

793

1.10

0.35

1.2

1.3

3.20

3.84

ug/l

0.80

737

Other contact dermatitis

544

0.88

0.35

1.3

2.73

3.91

ug/l

1.13

497

Sarcoidosis

319

1.16

0.35

1.7

1.4

2.18

3.62

ug/l

0.71

252

Other and unspecified dermatitis

323

3381

0.95

0.35

1.4

1.3

3.04

3.89

ug/l

1.06

288

2986

Noninfective enteritis and colitis

303

3171

0.95

0.35

1.3

3.63

4.00

ug/l

0.23

273

2852

Other disorders of veins

141

1503

0.93

0.34

1.7

1.4

2.51

4.26

ug/l

1.79

109

1201

Open wound of lower leg

742

0.90

0.34

1.3

4.41

3.92

ug/l

0.24

681

Superficial injury of ankle and foot

112

1210

0.92

0.34

1.3

3.33

4.24

ug/l

1.19

103

1133

Striae atrophicae

1.33

0.34

1.3

1.4

1.88

3.00

ug/l

0.96

Early lumbar disc prolapse, operated

1002

0.92

0.34

1.4

1.3

6.75

3.22

ug/l

0.48

925

Diseases of liver

992

0.92

0.34

1.3

1.4

3.41

4.06

ug/l

0.43

819

Diseases of inner ear

192

1751

1.06

0.33

1.5

1.4

2.96

4.35

ug/l

1.62

153

1432

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

109

1.29

0.33

1.0

1.7

2.74

6.40

ug/l

—

Use of teriflunomide

0.69

0.33

1.2

4.18

2.88

ug/l

—

Acute pancreatitis (for exclusion)

414

0.87

0.33

1.5

2.25

3.98

ug/l

1.36

343

Perforation of tympanic membrane

501

1.12

0.33

1.4

2.35

3.78

ug/l

1.85

455

Other disorders of patella

128

1372

0.93

0.32

1.4

1.3

3.26

3.57

ug/l

0.14

113

1216

Coxibs

255

1276

1.05

0.32

1.3

5.00

4.10

ug/l

0.28

239

1192

Ulcerative colitis (strict definition, require KELA)

112

1206

0.93

0.32

1.2

1.3

2.53

3.99

ug/l

2.99

103

1104

Other/unspecified enthesopathies of lower limb, excluding foot

370

0.86

0.32

1.2

1.4

2.90

3.95

ug/l

0.63

333

Disorders of skin appendages

470

4534

1.04

0.31

1.3

3.43

3.75

ug/l

0.80

420

4140

Injuries to the neck

194

2049

0.95

0.31

1.3

3.19

3.72

ug/l

0.89

176

1893

Chronic ulcer of skin, not elsewhere classified

101

1.29

0.31

1.5

1.6

3.71

2.89

ug/l

0.38

Abnormal findings on examination of blood, without diagnosis

132

1296

0.93

0.31

1.3

4.34

3.91

ug/l

0.16

111

1134

Rheumatism, unspecified

454

0.88

0.31

1.2

1.7

2.50

4.66

ug/l

1.05

355

DVT of lower extremities

408

1.13

0.31

1.2

1.4

1.98

4.04

ug/l

1.89

343

Lung diseases due to external agents

174

1.21

0.31

2.7

1.5

5.29

4.86

ug/l

0.07

146

Other osteochondropathies

337

0.86

0.31

1.4

2.34

3.27

ug/l

1.10

303

Open wound of shoulder and upper arm

0.73

0.31

1.4

1.3

4.79

2.79

ug/l

—

Patent foramen ovale

0.72

0.31

1.3

34.82

4.44

ug/l

—

Glaucoma

777

0.92

0.30

1.9

1.6

5.53

4.32

ug/l

0.22

558

Other factor of the environment

1.30

0.30

1.7

1.2

1.84

3.28

ug/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

276

2641

1.05

0.30

1.3

3.06

3.61

ug/l

1.24

242

2456

Sequelae of cerebrovascular disease

281

0.86

0.30

2.0

1.7

4.49

6.44

ug/l

0.26

204

Covid-19 suspected case

245

2338

1.05

0.30

1.3

3.42

3.69

ug/l

0.43

223

2145

Localized scleroderma [morphea]

1.28

0.30

1.4

1.3

3.38

2.68

ug/l

—

Syncope and collapse

229

2056

0.95

0.29

1.4

1.3

3.19

3.81

ug/l

1.19

201

1849

Conotruncal defects

107

0.74

0.29

1.1

1.3

14.43

4.66

ug/l

—

Cystic kidney disease

109

0.73

0.29

1.3

7.09

2.84

ug/l

—

Burns and corrosions of external body surface, specified by site

602

1.10

0.29

1.5

1.3

3.40

4.11

ug/l

0.61

558

Other congenital malformations of face and neck

238

0.84

0.29

1.2

1.3

3.76

3.12

ug/l

0.38

222

Palatinal maxillary operation

129

0.77

0.28

1.0

1.5

2.17

3.94

ug/l

—

119

Congenital malformations of heart and great arteries

798

1.08

0.28

1.5

1.4

7.60

5.00

ug/l

0.54

736

Puerperal sepsis

722

0.91

0.28

1.3

1.4

3.16

4.89

ug/l

1.12

605

Other noninfective gastroenteritis and colitis

149

1404

1.06

0.28

1.3

4.83

4.40

ug/l

0.12

130

1255

Asthma, including avohilmo

1024

5877

0.98

0.28

1.3

3.29

3.76

ug/l

1.38

931

5303

Disorders in reading

186

1.19

0.28

1.4

1.3

2.82

4.25

ug/l

1.16

174

Pain in thoracic spine

102

950

1.07

0.28

1.3

1.4

2.33

3.58

ug/l

2.72

838

Other headache syndromes

364

3769

0.96

0.28

1.3

2.74

3.79

ug/l

3.49

323

3366

Other predominantly sexually transmitted diseases, not elsewhere classified

354

3414

1.04

0.28

1.2

1.3

3.28

3.53

ug/l

0.57

331

3210

Conduction disorders

509

0.91

0.28

1.3

1.5

2.84

5.86

ug/l

1.98

416

Hernia of abdominal wall

155

1639

0.95

0.27

2.0

1.3

2.97

3.72

ug/l

0.66

119

1411

Other hammer toe(s) (acquired)

180

1.18

0.27

2.5

2.2

2.52

11.24

ug/l

1.06

Unspecified fall

266

2732

0.96

0.27

1.3

3.19

4.21

ug/l

2.88

239

2443

Vitiligo

1.23

0.27

1.3

3.10

2.78

ug/l

—

Benign neoplasm of meninges

172

0.81

0.27

2.3

1.8

1.09

5.00

ug/l

—

127

Visual disturbances

305

2935

1.04

0.27

1.5

1.3

3.07

3.90

ug/l

1.06

267

2605

Other and unspecified injuries of shoulder and upper arm

139

0.79

0.27

1.2

1.3

3.28

2.86

ug/l

0.24

125

Disorders of parathyroid gland

305

1.13

0.27

1.7

2.78

6.10

ug/l

0.92

213

Extrapyramidal and movement disorders

113

1059

1.07

0.26

1.2

1.5

2.54

4.35

ug/l

2.09

878

Persons encountering health services for specific procedures, not carried out

586

1.09

0.26

1.2

1.3

3.62

4.25

ug/l

0.50

547

Other peripheral vertigo

236

0.85

0.26

2.3

1.5

3.31

4.15

ug/l

0.25

200

Weight loss

395

1.12

0.26

1.6

1.4

7.83

3.93

ug/l

0.56

353

All influenza

123

1157

1.06

0.26

1.4

1.3

3.42

4.40

ug/l

1.18

108

1049

Toxic effects of substances chiefly nonmedicinal as to source

790

0.92

0.26

1.4

1.3

2.85

4.07

ug/l

1.94

737

Cough

250

2269

1.04

0.26

1.4

4.87

4.62

ug/l

0.10

214

1986

Primary coxarthrosis, bilateral

160

0.81

0.26

3.1

2.2

2.80

12.82

ug/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

231

2213

1.04

0.25

1.3

2.68

3.88

ug/l

3.33

207

1947

Dislocation, sprain and strain of joints and ligaments of thorax

160

1.19

0.25

2.8

1.4

3.34

3.10

ug/l

0.12

144

Psoriasis

107

1140

0.94

0.25

1.3

1.4

3.30

3.92

ug/l

0.56

988

Diseases of oral cavity, salivary glands and jaws

329

1631

1.04

0.25

1.4

1.3

3.79

4.28

ug/l

0.27

284

1439

Open wound of head

204

2055

0.96

0.25

1.3

1.4

3.24

4.07

ug/l

1.57

178

1817

Hypertrophy of breast in women and men

130

1375

0.94

0.25

1.3

1.4

2.17

3.89

ug/l

4.26

101

1177

Visual disturbances and blindness

319

3079

1.04

0.24

1.4

1.3

3.11

4.03

ug/l

1.28

279

2734

Other acute skin changes due to ultraviolet radiation

1.19

0.24

1.1

1.4

1.94

2.95

ug/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

111

1179

0.94

0.24

1.2

1.3

2.56

3.99

ug/l

2.84

102

1081

Conjunctivitis (acute, non atopic)

234

2238

1.04

0.24

1.3

3.51

3.85

ug/l

0.28

207

2040

Thyroiditis, unspecified

1.27

0.24

2.9

1.5

11.49

2.71

ug/l

0.39

Infections specific to the perinatal period

0.73

0.24

1.2

1.6

2.84

6.23

ug/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.72

0.24

1.5

1.3

17.89

4.57

ug/l

—

Herpesviral [herpes simplex] infections

258

2483

1.04

0.24

1.2

1.3

3.25

3.52

ug/l

0.37

232

2258

Other diseases of gallbladder

1.28

0.24

1.1

1.7

3.07

4.39

ug/l

—

Abnormal weight loss

293

1.13

0.24

1.3

1.5

2.57

4.35

ug/l

1.13

259

Adjustment and management of implanted device

212

0.85

0.24

1.2

1.5

3.44

5.01

ug/l

0.40

168

Hypertrophy of breast

130

1372

0.95

0.23

1.3

1.4

2.17

3.88

ug/l

4.21

101

1176

GI-bleeding

716

1.08

0.23

1.3

1.4

3.31

4.23

ug/l

0.95

626

Hypotension

199

1.16

0.23

1.3

1.5

2.68

4.17

ug/l

0.57

160

Cardiomyopathy (excluding other)

106

1.23

0.23

1.0

1.5

1.71

6.61

ug/l

—

Acute renal failure

243

0.86

0.23

1.6

4.15

4.37

ug/l

0.05

194

Sequelae of injuries of lower limb

390

0.90

0.23

1.7

1.4

2.33

3.93

ug/l

1.52

347

Other functional intestinal disorders

252

2252

1.04

0.23

1.3

1.4

3.10

4.67

ug/l

2.60

217

1977

Disease of hard tissues of teeth, NOS

322

1628

1.03

0.22

1.4

1.3

3.04

4.23

ug/l

1.08

280

1436

Restless leg syndrome

515

1.09

0.22

1.2

1.4

2.48

3.80

ug/l

1.21

447

Other sleep disorders

608

0.92

0.22

1.3

3.05

4.29

ug/l

1.20

548

Neonatal jaundice from other and unspecified causes

0.73

0.22

1.0

1.7

25.50

6.80

ug/l

—

261

0.88

0.22

1.3

2.1

1.85

7.79

ug/l

1.28

142

Diseases of the digestive system

176

1830

0.96

0.22

1.2

1.4

3.10

4.18

ug/l

1.98

156

1606

Generalized anxiety disorder

250

2592

0.96

0.22

1.2

3.14

3.71

ug/l

1.62

231

2451

Unspecified haematuria

667

0.93

0.22

1.5

1.4

4.02

4.81

ug/l

0.22

561

Glomerulonephritis

314

1.12

0.22

2.1

1.4

10.22

4.12

ug/l

0.55

278

Early complications of trauma

146

0.82

0.22

1.2

1.4

2.11

2.96

ug/l

0.76

128

!Aliquae complicationes praecoces traumatis

146

0.82

0.22

1.3

1.4

2.11

2.96

ug/l

0.76

128

Vasomotor rhinitis (mode)

284

0.88

0.22

1.1

1.4

1.30

4.15

ug/l

2.63

249

Induced delusional disorder

0.00

0.22

0.0

1.0

—

4.91

—

Congenital edentulism

0.00

0.21

0.0

1.1

—

2.70

—

Juvenile dermatomyositis

0.00

0.21

0.0

1.1

—

4.01

—

Polydactyly

0.00

0.21

0.0

1.2

—

4.97

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

267

1.13

0.21

1.2

1.3

3.23

3.16

ug/l

0.04

242

Alport

0.00

0.21

0.0

1.1

—

5.30

—

Injury of blood vessels of thorax

0.00

0.21

0.0

1.2

—

3.30

—

Other specified and unspecified disorders of choroid

0.00

0.21

0.0

1.1

—

4.56

—

Cystic disease of liver

0.00

0.21

0.0

1.0

—

1.26

—

Lesion of femoral nerve

0.00

0.21

0.0

1.5

—

0.34

—

Calculus of kidney and ureter

782

0.93

0.21

1.2

1.4

7.14

4.31

ug/l

0.54

679

Other crystal arthropathies

0.00

0.21

0.0

1.5

—

0.81

—

0.00

0.21

0.0

1.8

—

9.45

—

Dental pulpitis, including avohilmo

919

5855

1.02

0.21

1.3

3.62

3.59

ug/l

0.04

832

5316

Benign neoplasm: Cerebral meninges

156

0.83

0.21

2.4

1.8

1.09

5.24

ug/l

—

116

Vitamin deficiency

201

1.15

0.21

1.7

1.4

3.30

3.62

ug/l

0.11

182

Vitamin deficiency, wide

201

1.15

0.21

1.7

1.4

3.30

3.62

ug/l

0.11

182

Fracture of lumbar spine and pelvis

574

1.08

0.21

1.8

1.4

2.62

4.00

ug/l

1.82

498

Guillain-Barre syndrome

1.16

0.21

1.0

1.3

1.88

2.93

ug/l

—

Monoamine oxidase A inhibitors

344

1.11

0.21

1.6

1.4

2.74

4.72

ug/l

1.09

273

Viral and other specified intestinal infections

301

2847

1.03

0.21

1.3

3.92

4.20

ug/l

0.43

285

2722

Other enthesopathies

127

1335

0.95

0.21

1.2

1.5

2.48

4.52

ug/l

2.12

1106

Diplopia

498

1.09

0.21

1.6

1.4

4.73

3.97

ug/l

0.13

438

0.00

0.21

0.0

1.1

—

2.98

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.21

0.0

1.1

—

2.77

—

First line medication for Crohn's disease

1041

5721

0.98

0.21

1.4

1.3

2.85

3.86

ug/l

4.55

914

5223

Crystal arthropathies, rheuma endpoint

0.00

0.21

0.0

2.0

—

3.90

—

Blepharochalasis

314

0.89

0.20

1.1

2.1

1.25

6.84

ug/l

1.46

164

Torticollis

117

1.20

0.20

1.1

1.4

2.88

2.90

ug/l

0.01

106

Hypermobility syndrome

697

0.93

0.20

1.2

1.3

2.40

4.07

ug/l

2.89

652

Effects of other deprivation

0.00

0.20

0.0

1.0

—

4.43

—

Social disorders starting during childhood or adolescence

111

0.81

0.20

1.4

5.40

3.56

ug/l

—

103

Adhesive capsulitis of shoulder

324

0.89

0.20

1.1

1.7

1.94

5.42

ug/l

1.16

232

Social disorders starting during childhood or adolecense, excluding more controls

114

0.78

0.20

1.4

5.40

5.49

ug/l

—

105

Functional dyspepsia

146

1527

0.96

0.20

1.4

6.03

3.71

ug/l

0.46

127

1328

Diseases of the ear and mastoid process

1090

5560

0.98

0.20

1.3

3.64

ug/l

0.00

982

5030

Cutaneous abscess, furuncle and carbuncle

169

1761

0.96

0.20

1.3

2.91

3.82

ug/l

1.99

145

1602

Vascular dementia

0.00

0.20

0.0

1.9

—

6.48

—

Bitten or struck by other mammals

106

1117

0.95

0.20

1.5

1.3

4.12

4.05

ug/l

0.02

1033

IBD (strict) with PSC

1.20

0.20

1.5

1.3

2.68

3.19

ug/l

—

Other diseases of lip and oral mucosa

213

2055

1.04

0.19

1.2

1.4

2.61

4.03

ug/l

3.69

178

1781

Benign neoplasm: Tongue

1.18

0.19

1.3

1.00

2.77

ug/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

539

1.08

0.19

1.2

1.5

2.89

4.95

ug/l

1.11

421

Other and unspecified mononeuropathies of upper limb

1.22

0.19

2.1

1.4

13.11

2.36

ug/l

0.53

Dermatophytosis

327

1.10

0.19

1.6

1.4

2.26

4.41

ug/l

1.78

285

Noninfectious colitis NAS

753

1.06

0.19

1.3

1.4

3.86

4.19

ug/l

0.09

677

Eosinophilia

1.16

0.19

2.3

1.2

2.00

3.30

ug/l

—

Other specified/unspecified systemic involvement of connective tissue

249

0.88

0.19

1.1

1.4

2.92

3.98

ug/l

0.40

217

Urolithiasis

818

0.94

0.19

1.2

1.4

7.08

4.25

ug/l

0.59

711

Dislocation, sprain and strain of joints and ligaments at neck level

157

1635

0.96

0.19

1.2

1.3

3.19

3.82

ug/l

0.95

142

1520

Diarrhoea and gastroenteritis of presumed infectious origin

631

5571

1.02

0.18

1.4

1.3

3.26

3.61

ug/l

0.69

559

5087

Asthma and allergy

202

1924

1.04

0.18

1.2

1.3

4.06

3.81

ug/l

0.15

190

1803

Burns and corrosions

793

1.06

0.18

1.4

1.3

3.41

4.10

ug/l

0.69

736

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

108

1.19

0.18

1.2

1.6

10.29

4.94

ug/l

0.48

100

Heart failure and coronary heart disease

139

0.87

0.18

1.5

2.4

1.04

13.07

ug/l

—

Cystic kidney disease

128

1.17

0.18

1.3

9.02

2.82

ug/l

2.21

114

ILD medications: azathioprine

106

1009

1.05

0.18

1.4

1.3

2.28

4.12

ug/l

3.30

100

912

Early lumbar disc prolapse operation

980

0.95

0.18

1.4

1.3

6.70

3.47

ug/l

0.44

902

Acute epiglottitis

1.19

0.18

1.1

1.5

2.03

2.08

ug/l

—

Biguanides

569

3397

1.02

0.18

1.4

5.55

3.59

ug/l

6.70

512

2926

Ganglion

168

1618

1.04

0.17

1.3

3.57

3.90

ug/l

0.18

149

1435

Asthma and allergy, excluding more controls

202

1927

1.04

0.17

1.2

1.3

4.06

3.78

ug/l

0.17

190

1809

Heart failure and antihypertensive medication

217

0.90

0.17

1.5

52.14

5.83

ug/l

0.41

133

Gastrointestinal diseases

815

4015

1.02

0.17

1.4

1.3

4.00

3.75

ug/l

0.19

736

3745

Anorexia

110

1.19

0.17

2.3

1.2

18.24

2.95

ug/l

0.81

Speech and linguistic disorders, excluding more controls

115

1034

1.05

0.17

1.4

1.2

3.45

4.33

ug/l

1.60

110

994

Pityriasis rosea

1.11

0.17

1.3

1.68

3.51

ug/l

—

Disorders of continuity of bone

494

1.07

0.17

1.3

1.4

2.45

3.93

ug/l

1.65

440

Azathioprine

106

1011

1.05

0.17

1.4

1.3

2.28

4.20

ug/l

3.51

100

915

Complications specific to multiple gestation

1.19

0.17

1.3

1.4

2.15

2.59

ug/l

—

Inguinal hernia, bilateral

0.76

0.17

1.0

1.3

12.15

3.02

ug/l

—

Otitis externa, unspecified

742

0.94

0.17

1.3

3.88

3.97

ug/l

0.05

679

Inguinal or femoral hernia, bilateral

0.72

0.16

1.0

1.3

12.15

2.94

ug/l

—

Other benign neoplasms of skin

132

1375

0.96

0.16

1.4

2.64

4.10

ug/l

2.10

108

1158

Other sexually transmitted chlamydial diseases

136

1307

1.04

0.16

1.2

3.14

3.69

ug/l

0.84

131

1243

Vestibular neuronitis

234

1.11

0.16

2.8

1.5

4.31

4.85

ug/l

0.14

197

Glaucoma suspect

631

1.06

0.16

1.7

1.6

5.84

4.72

ug/l

0.17

458

Pain, not elsewhere classified

199

2055

0.97

0.16

1.3

2.84

3.58

ug/l

1.54

175

1852

Cervicobrachial syndrome

110

1150

0.96

0.16

1.3

1.4

2.40

3.88

ug/l

2.20

992

Budesonide

956

0.95

0.16

1.3

2.07

4.01

ug/l

3.76

859

Osteopathies and chondropathies

264

2391

1.03

0.16

1.5

1.4

3.33

3.99

ug/l

0.57

226

2057

Unspecified lump in breast

866

1.05

0.16

1.3

1.4

2.79

3.69

ug/l

1.24

731

Speech therapy

782

0.95

0.16

1.2

1.4

2.17

3.93

ug/l

3.20

642

Psoriasis (vulgaris), strict definition

1.20

0.16

1.5

1.4

2.23

2.95

ug/l

—

Excessive earwax

208

1968

1.03

0.15

1.4

3.32

4.15

ug/l

1.15

164

1697

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.79

0.15

1.5

1.2

2.68

2.96

ug/l

—

Nystagmus and other irregular eye movements

0.77

0.15

1.2

1.3

2.02

3.35

ug/l

—

Other specified/unspecified hearing loss

168

1.13

0.15

1.2

1.7

1.65

4.78

ug/l

1.20

137

Congenital musculoskeletal deformities of head, face, spine and chest

0.76

0.15

1.5

1.3

17.89

3.53

ug/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

421

0.92

0.15

1.4

1.3

3.28

3.72

ug/l

0.29

396

Migraine without aura, drug-induced

0.75

0.15

4.2

1.2

2.83

2.75

ug/l

—

Chondrocostal junction syndrome [Tietze]

197

1.12

0.15

1.4

2.71

3.64

ug/l

0.61

178

Any mental disorder

891

4525

0.99

0.15

1.4

1.3

3.84

3.74

ug/l

0.08

791

4061

Other specified/unspecified bacterial intestinal infections

197

1.12

0.15

1.3

1.5

7.42

3.52

ug/l

0.44

173

Subjective visual disturbances

149

1544

0.96

0.15

1.4

1.3

2.81

4.08

ug/l

2.10

127

1375

Exposure to smoke, fire and flames

1.13

0.15

1.0

1.3

2.07

3.17

ug/l

—

Abscess of anal and rectal regions

342

1.08

0.15

1.4

1.99

4.21

ug/l

2.22

311

Herpesviral [herpes simplex] infections

683

1.05

0.15

1.2

1.4

2.44

4.15

ug/l

2.79

614

Unspecific neurodegenerative disorder

103

0.86

0.15

1.5

2.6

5.40

17.51

ug/l

—

Bulimia nervosa (incl. atypical)

792

1.05

0.14

1.2

1.3

3.63

3.86

ug/l

0.15

751

Raynaud syndrome

635

0.94

0.14

1.3

2.99

3.60

ug/l

0.53

579

Diseases of external ear

163

1683

0.97

0.14

1.4

1.3

3.51

4.28

ug/l

0.92

141

1490

Other CVD (FINNGEN)

189

0.90

0.14

1.4

1.6

2.68

5.28

ug/l

1.00

155

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

265

1.07

0.14

1.5

1.1

3.71

2.44

ug/l

0.61

180

Other and unspecified injuries of wrist and hand

264

0.91

0.14

1.3

1.4

3.06

3.26

ug/l

0.19

241

Other symptoms and signs involving the circulatory and respiratory systems

285

1.09

0.14

1.2

1.4

1.71

3.83

ug/l

3.26

253

Other disorders of eye and adnexa

971

0.96

0.14

1.6

1.3

3.97

3.98

ug/l

0.00

877

Other disorders of bone

131

1264

1.04

0.14

1.3

2.84

3.90

ug/l

1.87

117

1132

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

204

1774

1.03

0.14

1.6

1.4

3.09

4.40

ug/l

1.24

144

1457

Diseases of the skin and subcutaneous tissue

915

4649

0.99

0.14

1.3

3.35

3.75

ug/l

0.82

811

4224

Atopic conjunctivitis

334

1.08

0.13

1.1

1.3

6.04

3.84

ug/l

0.40

307

Ménière disease

189

1.11

0.13

1.6

2.89

4.53

ug/l

0.44

152

Panic disorder

220

2258

0.97

0.13

1.3

3.87

3.77

ug/l

0.09

200

2134

Other and unspecified polyneuropathies, also in other diseases

247

1.09

0.13

1.4

1.6

1.72

4.03

ug/l

1.12

191

Mucosal proctocolitis

872

1.04

0.13

1.2

1.3

2.56

3.80

ug/l

2.32

802

Primary open-angle glaucoma, strict

138

0.87

0.13

4.3

2.0

3.10

13.03

ug/l

—

Obstructed labour due to maternal pelvic abnormality

551

0.94

0.13

1.7

1.5

2.39

3.76

ug/l

1.15

408

Embedded teeth, including avohilmo

153

1578

0.97

0.13

1.3

3.15

3.84

ug/l

1.43

148

1500

Implicit bacterial Sepsis

753

1.04

0.13

1.7

1.5

3.71

4.67

ug/l

0.44

631

Chondropathies

101

971

1.04

0.13

1.3

2.97

4.23

ug/l

1.69

876

Retinal vascular occlusion

1.17

0.13

4.2

1.5

3.71

5.89

ug/l

0.29

All dysplastic lesions of the cervix uteri

464

4678

0.98

0.13

1.3

3.51

3.15

ug/l

0.23

431

4304

Acne vulgaris

139

1435

0.97

0.13

1.3

3.52

3.93

ug/l

0.53

132

1371

Other disorders of cornea

273

0.92

0.13

1.2

1.5

2.47

4.07

ug/l

0.82

235

Anterior Iridocyclitis

897

0.96

0.13

1.6

1.3

5.23

3.60

ug/l

0.51

790

Iridocyclitis

100

1039

0.96

0.12

1.6

1.3

4.76

3.90

ug/l

0.26

915

Other protozoal intestinal diseases

1.18

0.12

1.6

1.2

3.15

2.73

ug/l

—

Eustachian salpingitis and obstruction

682

0.95

0.12

1.2

1.3

2.86

2.94

ug/l

0.06

625

Other extrapyramidal and movement disorders in other diseases

786

1.04

0.12

1.2

1.4

2.63

4.29

ug/l

1.52

670

Glucosamine medication

260

1.07

0.12

2.1

2.5

5.05

16.10

ug/l

0.76

Follow-up examination after treatment for conditions other than malignant neoplasms

429

2791

1.02

0.12

1.3

2.89

4.00

ug/l

2.76

380

2538

Pre-eclampsia or eclampsia

266

2604

1.02

0.12

1.5

1.3

3.35

3.27

ug/l

0.10

233

2342

Dementia

159

0.91

0.12

1.9

2.1

3.60

10.22

ug/l

0.74

Allergic asthma (mode), excluding more controls

296

2955

0.98

0.12

1.3

3.69

3.78

ug/l

0.07

272

2732

Psychiatric diseases

809

4002

1.01

0.12

1.4

1.3

3.80

3.83

ug/l

0.02

727

3580

Allergic asthma (mode)

296

2953

0.98

0.11

1.3

3.69

3.78

ug/l

0.07

272

2727

Spondylolisthesis/Spondylolysis

496

0.95

0.11

1.4

1.6

3.29

4.81

ug/l

0.60

389

Disorders of sclera, cornea, iris and ciliary body

326

3318

0.98

0.11

1.3

3.77

3.66

ug/l

0.07

284

2934

Polycystic kidney disease

1.16

0.11

1.2

1.3

6.88

2.79

ug/l

—

Cervical disc disorders

852

0.96

0.11

1.3

1.6

1.79

4.92

ug/l

2.18

648

Hypokalaemia

289

1.07

0.11

1.3

1.5

1.49

4.23

ug/l

2.14

235

All dysplastic lesions of the vulva

192

1.09

0.10

1.4

1.6

3.25

5.22

ug/l

0.51

162

Other specified/unspecified inflammatory spondylopathies

348

1.06

0.10

1.6

1.3

6.93

4.01

ug/l

0.35

320

Polyarthritis, unspecified

115

1.13

0.10

1.3

1.6

2.22

5.99

ug/l

0.96

Other (not insulin) diabetes medications

599

3597

0.99

0.10

1.4

5.38

3.49

ug/l

6.93

537

3119

Other strabismus

191

1946

0.98

0.10

1.3

4.38

4.02

ug/l

0.17

173

1779

Retinal vascular disorders

1.15

0.10

4.2

1.5

3.71

5.80

ug/l

0.28

Crohn's disease of small intestine

486

1.05

0.10

1.3

2.35

4.18

ug/l

2.63

448

Other abnormal findings in urine

1.14

0.10

1.2

1.4

2.87

2.40

ug/l

—

Other conjunctival vascular disorders and cysts

1.14

0.10

1.2

1.4

1.50

2.73

ug/l

—

Strabismus

207

2108

0.98

0.10

1.4

1.3

4.19

4.01

ug/l

0.08

187

1914

Malignant neoplasm of head and neck

1.14

0.10

1.0

1.1

1.55

3.43

ug/l

—

Other, unspecified and serous retinal detachments

1.11

0.10

2.0

1.3

1.48

2.84

ug/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.15

0.09

1.4

1.3

3.97

3.07

ug/l

—

Adverse effects, not elsewhere classified

184

1880

0.98

0.09

1.3

3.56

3.83

ug/l

0.15

168

1712

Other and unspecified acne

145

0.89

0.09

1.3

3.95

3.32

ug/l

0.21

137

Acute appendicitis, with complications

684

1.04

0.09

1.3

1.4

9.73

3.42

ug/l

0.52

583

Acute and subacute iridocyclitis

848

0.97

0.09

1.7

1.3

5.28

3.58

ug/l

0.51

744

Myocardial infarction, without ST-elevation

132

0.90

0.09

2.0

2.1

0.42

12.58

ug/l

—

Other fall from one level to another

162

1583

1.02

0.09

1.4

1.3

3.78

4.26

ug/l

0.52

147

1471

LSIL lesion of the cervix uteri

180

1838

0.98

0.09

1.3

2.77

3.52

ug/l

1.68

168

1691

Carcinoma in situ of cervix uteri

189

1852

1.02

0.09

1.1

1.3

4.76

3.47

ug/l

0.36

178

1744

Allergic rhinitis

371

3719

0.99

0.09

1.3

3.97

3.79

ug/l

0.14

344

3414

AV-block

163

0.91

0.09

1.1

1.5

2.33

3.40

ug/l

0.98

121

Other sexually transmitted chlamydial diseases

208

2120

0.98

0.09

1.2

1.3

3.22

3.74

ug/l

1.32

201

2031

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

110

1095

0.97

0.09

1.4

6.17

4.73

ug/l

0.38

1009

General examination and investigation of persons without complaint and reported diagnosis

535

2824

0.99

0.08

1.4

1.3

4.05

4.06

ug/l

0.01

483

2568

Ulcerative rectosigmoiditis

451

0.95

0.08

1.1

1.3

2.73

4.07

ug/l

1.20

410

Deep bite that required surgery

107

1.12

0.08

1.2

1.3

4.52

2.92

ug/l

0.51

Viral and other specified intestinal infections

391

3723

1.01

0.08

1.3

3.66

3.99

ug/l

0.71

370

3516

Other shoulder lesions

532

0.96

0.08

1.5

1.4

2.28

3.89

ug/l

2.09

475

Allergic contact dermatitis

115

1180

0.97

0.08

1.2

1.3

3.02

3.83

ug/l

1.05

1062

Retention of urine

530

1.04

0.08

1.3

1.4

3.10

4.17

ug/l

0.88

460

Other immunodeficiencies

1.03

0.08

1.3

1.55

3.30

ug/l

—

Cardiodefibrillation

154

0.91

0.08

1.3

2.2

2.92

10.71

ug/l

—

Otitis externa

141

1378

1.02

0.08

1.4

1.3

3.71

4.04

ug/l

0.31

122

1233

1.03

0.08

1.0

2.6

—

2.96

—

Divergent concomitant strabismus

420

1.05

0.08

1.3

1.4

2.56

4.25

ug/l

1.28

377

Congenital malformations of the respiratory system

0.83

0.08

1.2

1.3

2.48

4.61

ug/l

—

Other respiratory disorders and diseases

267

0.94

0.08

1.3

1.6

4.82

4.73

ug/l

0.01

212

Other diseases of the respiratory system

267

0.94

0.08

1.3

1.6

4.82

4.73

ug/l

0.01

212

Type 2 diabetes, definitions combined, including avohilmo

606

3564

0.99

0.08

1.5

1.3

6.28

3.31

ug/l

2.23

542

3089

Toxic effect of carbon monoxide

0.77

0.08

1.2

1.3

1.94

3.15

ug/l

—

Migraine with aura and triptan purchases

255

2589

0.98

0.08

1.2

1.3

3.39

3.60

ug/l

0.32

242

2405

Other disorders of iris and ciliary body

0.84

0.07

1.7

1.5

2.85

3.38

ug/l

—

Other specified disorders of muscle

0.84

0.07

2.7

1.5

3.25

2.96

ug/l

—

Maternal care for other conditions predominantly related to pregnancy

388

3849

0.99

0.07

1.2

1.3

3.92

3.17

ug/l

0.43

356

3531

Macular pucker

0.83

0.07

2.7

2.2

—

9.45

ug/l

—

Other localized connective tissue disorders

1.08

0.07

1.4

1.3

3.34

2.88

ug/l

—

Persistent delusional disorders

176

1.08

0.07

2.9

1.5

3.08

4.63

ug/l

0.47

149

Pleural effusion

137

1.10

0.07

1.3

1.8

3.82

5.62

ug/l

—

102

Respiratory distress of newborn

1.12

0.07

1.9

1.7

9.50

6.65

ug/l

0.30

Benign neoplasm: salivary glands, exclude unknown (D119)

186

1.08

0.07

1.1

1.5

3.95

4.72

ug/l

0.17

152

Other and unspecified injuries of neck

0.86

0.07

1.1

1.4

1.90

3.33

ug/l

—

Venous complications and haemorrhoids in the puerperium

0.85

0.07

1.3

9.33

3.07

ug/l

—

0.87

0.07

1.0

2.5

—

26.40

—

Pruritus

728

1.03

0.07

1.3

3.21

3.61

ug/l

0.18

660

Other bursopathies

296

0.95

0.07

1.2

1.5

2.96

4.34

ug/l

0.67

240

Pacemaker

225

0.94

0.07

1.2

1.8

2.66

4.95

ug/l

0.68

163

Dependent personality disorder

0.82

0.07

1.1

1.3

1.63

2.90

ug/l

—

Lichen planus, including avohilmo

428

0.96

0.07

1.3

1.5

2.86

4.14

ug/l

0.74

333

Other obstructive and reflux uropathy

363

1.05

0.07

1.3

4.52

3.39

ug/l

0.43

338

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.06

0.07

1.2

1.3

3.13

2.55

ug/l

—

Post-traumatic wound infection, not elsewhere classified

1.03

0.07

1.2

1.4

1.73

3.13

ug/l

—

Continuous positive airway pressure

256

1.05

0.07

1.3

1.5

6.15

8.47

ug/l

0.29

179

Other/unspecified synovitis and tenosynovitis

549

0.97

0.06

1.3

1.4

2.49

3.95

ug/l

1.70

486

All-cause Heart Failure

309

0.96

0.06

2.0

1.9

30.67

6.57

ug/l

0.37

181

Other diseases of anus and rectum

105

1024

1.02

0.06

1.4

1.5

3.45

4.64

ug/l

0.98

865

Other nonscarring hair loss

1.11

0.06

1.2

1.3

3.14

2.85

ug/l

0.14

Cervicalgia

102

997

1.02

0.06

1.4

2.40

3.92

ug/l

2.18

865

Propionic acid derivatives

264

1345

0.99

0.06

1.4

1.3

3.69

4.47

ug/l

0.73

247

1255

Use of fingolimod

104

0.86

0.06

1.3

1.2

1.43

2.73

ug/l

—

Other abnormal findings of blood chemistry

203

0.94

0.06

1.4

1.3

1.60

2.59

ug/l

2.01

182

Convulsions, not elsewhere classified

170

1705

0.98

0.06

1.3

3.27

4.02

ug/l

1.62

156

1590

Heart failure, strict

315

0.96

0.06

2.0

1.9

30.67

6.48

ug/l

0.37

186

Brachial plexus disorders

709

0.97

0.06

1.3

2.14

3.60

ug/l

2.61

637

Benign lipomatous neoplasm

820

0.98

0.06

1.4

1.5

2.51

4.20

ug/l

1.66

665

Chronic gastritis

454

1.04

0.05

1.6

1.7

5.25

5.04

ug/l

0.02

337

Other and unspecified psoriasis

178

1.07

0.05

1.2

1.5

3.18

4.70

ug/l

0.41

152

Anogenital herpesviral [herpes simplex] infection

920

1.02

0.05

1.3

2.74

3.84

ug/l

1.56

866

Enteropathic arthropathies

129

1.09

0.05

1.3

1.5

2.53

3.92

ug/l

0.71

113

Contusion of ankle

316

1.05

0.05

1.4

3.42

4.21

ug/l

0.42

293

Primary open-angle glaucoma

166

0.93

0.05

4.1

1.9

2.72

12.25

ug/l

—

Disorders of calcium metabolism

149

1.07

0.05

1.8

1.6

1.83

5.26

ug/l

1.11

121

Disorders of psychological development

160

1505

0.99

0.05

1.4

1.3

3.94

4.35

ug/l

0.41

153

1436

Other appendicitis

366

1.04

0.05

1.2

1.4

3.67

3.73

ug/l

0.03

325

Radiculopathy

366

1.04

0.05

1.2

1.4

1.85

3.85

ug/l

1.71

295

Assault by bodily force

586

0.97

0.05

1.2

1.3

3.65

3.62

ug/l

0.02

553

Chronic hepatitis, not elsewhere classified

110

0.91

0.05

1.7

1.5

4.99

3.95

ug/l

—

Pollen allergy

270

2638

1.01

0.05

1.3

4.12

3.96

ug/l

0.11

254

2468

Pre-eclampsia

257

2544

1.01

0.05

1.5

1.3

3.37

3.26

ug/l

0.15

228

2291

Spinal stenosis

376

1.03

0.04

1.6

2.0

1.36

9.69

ug/l

1.70

204

Multiple gestation

140

1380

1.01

0.04

1.5

1.3

3.83

3.18

ug/l

0.71

132

1244

Lung cancer and mesothelioma

1.10

0.04

1.7

2.5

2.59

17.53

ug/l

—

Injury of muscle and tendon at lower leg level

373

0.96

0.04

1.2

1.4

2.31

3.51

ug/l

0.89

320

Chronic sinusitis

297

2942

1.01

0.04

1.4

1.3

3.06

3.76

ug/l

0.76

256

2590

Migraine without aura and triptan purchases

268

2657

1.01

0.04

1.3

3.32

3.55

ug/l

0.20

250

2459

Nontoxic single thyroid nodule

269

1.04

0.04

1.1

1.5

1.87

4.03

ug/l

1.31

226

Implicit bacterial Sepsis

634

1.02

0.04

1.8

1.5

3.82

4.97

ug/l

0.43

526

Migraine without aura

332

3344

0.99

0.04

1.3

3.61

ug/l

0.00

310

3075

Neurological diseases, wide definition

467

2359

0.99

0.04

1.3

4.13

ug/l

0.00

438

2202

Corneal ulcer

105

1066

0.98

0.04

1.2

1.3

4.45

3.86

ug/l

0.19

961

Pedestrian injured in collision with pedal cycle

119

0.92

0.04

1.3

1.4

3.83

2.76

ug/l

0.32

106

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

121

1.08

0.03

2.1

1.4

3.72

3.68

ug/l

0.02

114

LSIL lesion of the vulva

121

1.08

0.03

1.5

1.7

4.28

4.69

ug/l

—

Ventricular septal defect, a heart condition

189

0.95

0.03

1.4

3.13

4.66

ug/l

1.24

172

Viral haemorrhagic fevers, not elsewhere classified/unspecified

230

0.96

0.03

1.6

1.4

3.29

3.26

ug/l

0.01

203

Disorders of vitreous body and globe

878

0.98

0.03

1.2

1.7

2.62

5.59

ug/l

1.63

618

All dysplastic lesions of the cervix uteri, vagina or vulva

490

4801

1.01

0.03

1.3

3.45

3.19

ug/l

0.16

448

4389

Disorders of vitreous body

846

1.02

0.03

1.2

1.7

2.60

5.68

ug/l

1.61

590

Twin gestation

133

1345

0.99

0.03

1.5

1.3

3.85

3.19

ug/l

0.68

125

1214

Non-allergic asthma (mode), excluding more controls

108

1083

0.99

0.03

1.4

3.23

4.56

ug/l

1.50

969

LSIL lesion of the cervix uteri, vagina or vulva

200

1984

1.01

0.03

1.3

2.84

3.48

ug/l

1.39

181

1806

Viral agents as the cause of diseases classified to other chapters

122

1.07

0.02

1.1

1.3

3.09

2.66

ug/l

0.29

106

Benign neoplasm: Ascending colon

122

1.07

0.02

1.4

2.0

1.68

6.76

ug/l

—

Heart failure and bmi 25plus

129

1.05

0.02

2.5

2.1

0.58

2.87

ug/l

—

Abnormal findings on diagnostic imaging of central nervous system

269

0.97

0.02

1.3

1.4

2.92

3.70

ug/l

0.50

245

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

706

4851

1.00

0.02

1.5

1.3

3.63

3.71

ug/l

0.07

601

4322

Aneurysms, operations, SAH

281

1.03

0.02

1.3

1.5

2.24

4.51

ug/l

1.13

210

Infectious mononucleosis

136

1347

1.01

0.02

1.3

3.61

3.98

ug/l

0.30

130

1285

Sicca syndrome [Sjögren]

289

0.97

0.02

1.3

1.6

2.40

4.46

ug/l

1.06

233

Gingivitis and periodontal diseases

752

3891

1.00

0.02

1.4

1.3

3.14

3.89

ug/l

1.76

669

3447

Other/unspecified dorsalgia

257

2562

0.99

0.02

1.3

1.4

2.87

3.88

ug/l

2.11

222

2292

Heart failure,strict

310

0.98

0.02

2.0

1.9

30.67

6.60

ug/l

0.37

185

Selective serotonin reuptake inhibitors

856

4456

1.00

0.02

1.3

3.29

3.91

ug/l

1.64

780

4039

Cerebral palsy and other paralytic syndromes

479

0.98

0.02

1.7

1.4

4.69

4.43

ug/l

0.05

429

Superficial injury of abdomen, lower back and pelvis

117

1181

0.99

0.02

1.2

1.3

3.10

4.10

ug/l

1.53

111

1101

Anti-inflammatory and antirheumatic products, non-steroids

269

1345

1.01

0.02

1.3

3.83

4.47

ug/l

0.56

250

1255

Achilles tendinitis

272

1.03

0.02

1.1

1.5

2.90

4.01

ug/l

0.48

221

Polypectomy (DHB20)

117

0.94

0.01

1.4

1.5

4.50

3.87

ug/l

0.13

Hyperparathyroidism

215

0.97

0.01

2.2

1.7

1.82

4.70

ug/l

—

141

Fracture of femur

301

1.02

0.01

1.7

1.6

2.53

4.39

ug/l

1.08

237

Injuries to the abdomen, lower back, lumbar spine and pelvis

231

2296

1.00

0.01

1.4

1.3

3.08

3.92

ug/l

1.86

206

2086

Fibroblastic disorders

448

0.98

0.01

1.5

1.6

3.05

4.65

ug/l

0.69

354

Bacterial Sepsis

112

965

0.99

0.01

1.8

1.4

3.57

4.85

ug/l

0.79

827

Ptosis of eyelid

187

0.96

0.01

1.2

1.8

1.08

4.91

ug/l

1.75

143

Cervicocranial syndrome

522

1.02

0.01

1.7

1.4

2.39

3.81

ug/l

1.41

455

Benign mammary dysplasia

562

1.01

0.01

1.9

1.5

12.34

4.04

ug/l

0.49

467

Generalized epilepsy, strict definition

213

1.03

0.01

1.2

1.3

3.04

3.40

ug/l

0.20

196

Carrier of infectious disease

213

1.03

0.01

1.2

1.3

2.07

3.03

ug/l

1.36

195

Glomerular diseases

597

0.99

0.01

1.8

1.3

7.36

3.73

ug/l

0.55

531

HSIL lesion of the cervix uteri, vagina or vulva

347

3479

1.00

0.01

1.3

3.74

3.16

ug/l

0.27

319

3206

Postprocedural disorders of nervous system

807

0.99

0.01

1.5

1.3

4.71

4.03

ug/l

0.16

751

Distal bite

354

0.98

0.00

1.4

4.54

5.51

ug/l

0.35

326

Cardiac murmurs and other cardiac sounds

837

0.99

0.00

1.4

4.20

5.16

ug/l

0.75

776

Acute laryngitis and tracheitis

153

1498

1.00

0.00

1.3

3.81

4.35

ug/l

0.38

144

1419

Sequelae of infectious and parasitic diseases

226

0.97

0.00

1.3

1.4

1.89

3.51

ug/l

1.03

196

Benign neoplasm of eye and adnexa

264

1.02

0.00

1.1

1.5

2.78

4.39

ug/l

0.71

220

Injury of muscle and tendon at hip and thigh level

286

0.98

0.00

1.6

1.4

4.09

4.20

ug/l

0.03

245

Other diseases of liver

576

0.99

0.00

1.2

1.4

3.92

4.23

ug/l

0.14

477

Vocal cord dysfunction

748

1.01

0.00

1.4

3.82

3.79

ug/l

0.01

652

Type 2 diabetes, definitions combined

593

3476

1.00

0.00

1.4

1.3

5.25

3.52

ug/l

5.72

531

3014

Pedal cyclist injured in transport accident

152

1514

1.00

0.00

1.3

2.95

4.04

ug/l

2.51

142

1382

Non-allergic asthma (mode)

109

1085

0.99

0.00

1.4

3.70

4.56

ug/l

0.56

970

Other disorders of skin and subcutaneous tissue

321

2849

1.00

0.00

1.4

3.97

3.93

ug/l

0.02

270

2444

Chronic pancreatitis

122

0.98

0.00

1.5

1.8

3.10

6.16

ug/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

120

1160

1.00

0.00

1.4

6.39

4.64

ug/l

0.55

108

1067

Vasomotor and allergic rhinitis

407

3994

1.00

0.00

1.3

3.85

3.79

ug/l

0.05

369

3640

Atrial fibrillation and flutter with reimbursement

130

0.98

0.00

2.1

1.9

1.47

8.57

ug/l

—

Stenosis and insufficiency of lacrimal passages

292

0.99

0.00

1.2

1.6

4.32

4.02

ug/l

0.08

244

Hallux rigidus

175

1.03

0.00

1.3

2.1

1.83

10.08

ug/l

—

Streptococcal septicaemia

185

1.03

0.00

2.6

1.5

2.70

3.55

ug/l

0.27

160

Myalgia

203

2026

1.00

0.00

1.4

1.3

3.56

3.87

ug/l

0.17

189

1825

severe traumatic brain injury, does not include concussion

359

1.00

0.00

1.3

1.5

2.34

4.15

ug/l

1.45

307

Viral pneumonia

552

1.00

0.00

1.4

3.28

4.04

ug/l

0.38

498

Benign neoplasm: Parotid gland

169

1.01

0.00

1.1

1.5

4.28

4.80

ug/l

0.10

138

Nonalcoholic fatty liver disease

305

0.98

0.00

1.3

1.5

4.27

4.48

ug/l

0.06

257

Plantar fascial fibromatosis

355

0.99

0.00

1.6

1.5

3.24

3.89

ug/l

0.33

290

Non-selective monoamine reuptake inhibitors

112

1082

1.00

0.00

1.3

1.6

2.44

5.12

ug/l

2.21

844

Other/unspecified soft tissue disorders related to use, overuse and pressure

114

0.96

0.00

1.9

1.6

11.71

3.82

ug/l

0.44

105

1.02

0.00

1.5

1.3

2.70

3.25

ug/l

—

Benign neoplasm: Conjunctiva

108

1.02

0.00

1.2

1.3

3.18

3.14

ug/l

0.01

Galactorrhea

122

0.98

0.00

1.0

1.3

2.92

2.86

ug/l

0.02

110

Carcinoma in situ of cervix uteri, endocervix

148

1.01

0.00

1.1

1.4

2.87

2.44

ug/l

0.22

132

Coeliac disease

798

1.00

0.00

1.1

1.4

2.77

3.95

ug/l

1.81

716

Polyuria

572

1.00

0.00

1.3

1.4

2.53

4.00

ug/l

1.81

496

Primary hyperparathyroidism

151

0.99

0.00

2.3

1.8

1.88

6.03

ug/l

—

102

Contact with machinery

149

1.01

0.00

1.7

1.2

1.42

2.98

ug/l

3.79

127

Open bite that required surgery (Lefort1 or BSSO)

139

1.01

0.00

1.1

1.3

3.43

3.35

ug/l

0.03

128

Faecal incontinence

209

1.00

0.00

1.4

1.3

3.13

2.97

ug/l

0.05

168

Other peripheral vascular diseases

371

1.00

0.00

1.4

2.83

3.15

ug/l

0.18

328

Persons encountering health services for examination and investigation

563

2824

1.00

0.00

1.4

1.3

4.20

4.06

ug/l

0.06

509

2568

Keratitis

214

2143

1.00

0.00

1.2

1.3

3.44

3.78

ug/l

0.22

185

1920

HSIL lesion of the cervix uteri

337

3371

1.00

0.00

1.3

3.79

3.17

ug/l

0.29

312

3114

Chronic kidney disease

331

1.01

0.00

1.9

1.5

2.79

4.45

ug/l

0.77

261

Viral agents as the cause of diseases classified to other chapters

159

1.01

0.00

1.1

1.3

3.11

2.66

ug/l

0.40

139

203

0.99

0.00

1.4

1.5

9.93

5.93

ug/l

0.39

187

Congenital deformities of feet

205

0.98

0.00

1.4

1.3

3.85

3.41

ug/l

0.26

190

Benign neoplasm: Skin, unspecified

125

0.96

0.00

1.3

1.4

3.41

3.87

ug/l

0.13

108

172

1.01

0.00

1.5

1.6

10.93

6.14

ug/l

0.40

157

Congenital malformations of the respiratory system

0.98

0.00

1.2

1.3

2.48

4.99

ug/l

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

0.0

1.1

—

2.15

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.0

—

3.42

—

Burn and corrosion of other internal organs

0.00

0.0

1.2

—

5.56

—

Periodic paralysis

0.00

0.0

1.2

—

1.45

—

Fetal blood loss

0.00

0.0

1.6

—

5.52

—

Methaemoglobinaemia

0.00

0.0

1.0

—

8.30

—

APECED

0.00

0.0

1.0

—

3.82

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.0

1.0

—

2.94

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.2

—

6.98

—

Pectus carinatum

0.00

-0.00

0.0

1.2

—

2.30

—

Pectus carinatum

0.00

-0.00

0.0

1.2

—

2.30

—

Malignant neoplasm of accessory sinuses

0.00

-0.00

0.0

1.0

—

2.50

—

Corrosions classified according to extent of body surface involved

0.00

-0.00

0.0

1.0

—

2.11

—

Other neonatal haemorrhages

0.00

-0.00

0.0

1.4

—

2.40

—

Fetus and newborn affected by maternal use of alcohol

0.00

-0.00

0.0

1.2

—

1.67

—

Other conditions related to polyarteritis nodosa

0.00

-0.00

0.0

1.2

—

3.86

—

Failure of sterile precautions during surgical operation

0.00

-0.00

0.0

1.0

—

2.57

—

Other and unspecified pemphigus

0.00

-0.00

0.0

1.0

—

3.54

—

ILD, hospital admissions 3, with pneumonia sepsis

0.92

-0.00

2.2

1.5

8.56

3.60

ug/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

260

1.00

-0.00

1.5

1.4

2.85

4.13

ug/l

0.50

229

Pityriasis alba

0.00

-0.00

0.0

1.0

—

5.68

—

Type 2 diabetes, strict (exclude DM1)

592

3477

1.00

-0.00

1.4

1.3

5.25

3.53

ug/l

5.68

531

3009

Pityriasis rubra pilaris

0.00

-0.00

0.0

1.1

—

3.18

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.0

—

3.19

—

Other and unspecified nail disorders

0.98

-0.00

1.5

1.4

2.96

2.67

ug/l

—

Apocrine sweat disorders, other sweat gland disorders

0.00

-0.00

0.0

1.0

—

5.37

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.2

—

1.67

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.0

—

6.81

—

Dislocations, sprains and strains involving multiple body regions

0.00

-0.00

0.0

1.3

—

1.51

—

Osteochondrosis of ankle, juvenile

0.94

-0.00

1.3

4.75

3.48

ug/l

—

Other and unspecified intracranial injuries

0.94

-0.00

1.3

2.44

3.32

ug/l

—

Acute otitis externa, noninfective

0.96

-0.00

2.0

1.4

4.10

2.98

ug/l

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.2

—

5.73

—

Congenital malformations of anterior segment of eye

0.94

-0.00

2.8

1.2

1.85

2.74

ug/l

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

-0.00

0.0

1.0

—

Cerebral arteritis

0.00

-0.00

0.0

1.0

—

3.30

—

Degeneration of iris and ciliary body

0.00

-0.00

0.0

1.3

—

3.28

—

Other dialysis

0.89

-0.00

1.8

1.4

0.96

3.67

ug/l

—

Poisoning by medicine, drug-induced

0.94

-0.00

1.2

1.3

3.32

2.73

ug/l

—

Eosinophilic disease (BM)

1.02

-0.00

2.3

1.4

2.00

3.43

ug/l

—

Brain glioblastoma

0.00

-0.00

0.0

1.0

—

2.76

—

Deficiency of other/unspecified vitamins

0.00

-0.00

0.0

1.4

—

4.43

—

Preparatory care for dialysis

0.88

-0.00

4.4

1.4

0.94

3.10

ug/l

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.2

—

4.70

—

Disorder of mineral metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

3.93

—

Other injuries of upper limb, level unspecified

0.85

-0.00

1.8

1.4

8.91

3.40

ug/l

—

Forearm

0.00

-0.00

0.0

1.0

—

7.18

—

Other and unspecified disorders of psychological development

0.92

-0.00

1.4

3.93

6.00

ug/l

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.2

—

1.04

—

Other and unspecified injuries of thorax

0.98

-0.00

1.0

1.3

8.20

2.87

ug/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.4

—

4.12

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.0

—

3.69

—

Contact with other specified venomous plants

0.00

-0.00

0.0

1.3

—

1.47

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

2.52

—

Parapsoriasis

0.95

-0.00

1.4

1.2

2.02

3.27

ug/l

—

Other and unspecified vaccines and biological substances

0.98

-0.00

1.0

1.1

1.79

3.16

ug/l

—

Neuroendocrine tumor and carcinoma of pancreas

0.00

-0.00

0.0

1.0

—

5.71

—

Environmental-pollution-related condition

0.00

-0.00

0.0

1.2

—

3.44

—

Clubfoot

0.87

-0.00

1.2

2.83

3.36

ug/l

—

Evidence of alcohol involvement determined by level of intoxication

0.96

-0.00

1.1

1.3

7.09

3.11

ug/l

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

-0.00

0.0

1.1

—

1.37

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.1

—

3.21

—

Exposure to sunlight

0.00

-0.00

0.0

1.3

—

1.85

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.0

—

3.29

—

Exposure to ignition of highly flammable material

0.00

-0.00

0.0

1.2

—

3.93

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.0

—

4.23

—

Hookworm diseases

0.00

-0.00

0.0

1.0

—

4.42

—

Hookworm diseases

0.00

-0.00

0.0

1.0

—

5.01

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.0

—

6.51

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS